This archive includes all weekly updates of the figures on the COVID-19 vaccination programme in the Netherlands.
28 December 2021| 4:00 PM
Vaccination figures: 20-26 December 2021
By Sunday 26 December, it is estimated that more than 24.6 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.3 million were second vaccinations.
Vaccination coverage for the basic series
It is estimated that 89.1% of all people over 18 have received at least one vaccination in the basic series, and 85.9% have completed the basic series. It is estimated that 87.3% of all people over 12 have received at least one vaccination in the basic series, and 84.3% have completed the basic series.
Major increase in booster vaccinations
By 26 December, more than 3,110,000 booster vaccinations and third vaccinations had been administered. Nearly 2,364,400 people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, an estimated 624,700 people had received a booster vaccination in a care institution or hospital by 26 December. Since 6 October 2021, more than 130,000 people with severely impaired immunity have received their third vaccination from the GGD.
Vaccination coverage for booster vaccination
It is estimated that 20.9% of all people over 18 have now received a booster vaccination.
Vaccination figures: 6 January – 26 December 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 51 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,706 | 67,064 | 135,769 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,260 | 187,141 | 377,401 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,890 | 373,750 | 752,640 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,576 | 567,017 | 1,142,593 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,207 | 842,732 | 1,705,939 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 804,911 | 778,385 | 1,583,296 |
GGD | 61-65 | 1956-1960 | 148,993 | 161,171 | 310,164 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,034,939 | 970,849 | 2,005,778 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,047,776 | 770,289 | 1,818,065 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 901,183 | 818,543 | 1,719,726 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 792,900 | 665,163 | 1,458,063 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 769,811 | 679.143 | 1,448,954 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 780,844 | 674,181 | 1,455,025 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 765,723 | 630,801 | 1,396,524 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,239,948 | 909,753 | 2,149,701 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 785,562 | 689,701 | 1,475,263 |
GGD | Unknown | Unknown | 4,760 | 3,661 | 8,421 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,320,732 | 11,361,062 | 24,681,794 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 51, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 644,860 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 51, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.3% | 84.3% |
18 years and older | 2003 and before | 89.1% | 85.9% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 51, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
21 December 2021| 4:00 PM
Vaccination figures: 13-19 December 2021
By Sunday 19 December, it is estimated that more than 24.6 million first and second vaccinations had been administered in the Netherlands. More than 13.3 million of those were first vaccinations, and more than 11.3 million were second vaccinations.
It is estimated that 89% of all people over 18 have received at least one vaccination, and 85.9% are fully vaccinated. According to estimates, 87.2% of all people over 12 years old have now received at least one vaccination, and 84.3% are fully vaccinated.
Booster vaccinations and third vaccinations
By 19 December, more than 1,956,600 booster vaccinations and third vaccinations had been administered. Nearly 1,343,000 people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, an estimated 486,000 people had received a booster vaccination in a care institution or hospital by 19 December. Since 6 October 2021, 127,600 people with severely impaired immunity have received their third vaccination from the GGD.
Vaccination figures: 6 January – 19 December 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 50 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,697 | 67,040 | 135,737 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,240 | 187,052 | 377,292 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,851 | 373,598 | 752,449 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,568 | 566,771 | 1,142,339 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,170 | 842,045 | 1,705,215 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 804,807 | 777,395 | 1,582,202 |
GGD | 61-65 | 1956-1960 | 148,875 | 160,095 | 308,970 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,034,833 | 969,562 | 2,004,395 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,047,566 | 769,019 | 1,816,585 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 900,859 | 817,237 | 1,718,096 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 792,542 | 663,833 | 1,456,375 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 769,298 | 677,304 | 1,446,602 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 780,008 | 671,734 | 1,451,742 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 764,694 | 628,075 | 1,392,769 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,238,357 | 904,500 | 2,142,857 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 782,714 | 684,609 | 1,467,323 |
GGD | Unknown | Unknown | 4,327 | 3,296 | 7,623 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,312,160 | 11,334,883 | 24,647,043 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 50, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 644,679 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 50, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.2% | 84.3% |
18 years and older | 2003 and before | 89.0% | 85.9% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 50, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
14 December 2021| 16:10 PM
Vaccination figures: 6 December to 12 December 2021
By Sunday 12 December, it is estimated that more than 24.5 million first and second vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.2 million were second vaccinations.
It is estimated that 88.9% of all people over 18 have received at least one vaccination, and 85.8% are fully vaccinated. According to estimates, 87.2% of all people over 12 years old have now received at least one vaccination, and 84.0% are fully vaccinated.
Booster vaccinations and third vaccinations
By Sunday 12 December, nearly 1.17 million booster vaccinations and third vaccinations had been administered. More than 630,600 people have received their booster vaccination from the Municipal Public Health Services (GGDs). In addition, an estimated 417,000 people had received a booster vaccination in a care institution or hospital by 12 December.
Since 6 October 2021, more than 121,500 people with severely impaired immunity have received their third vaccination from the GGD. Due to a technical malfunction at the GGD, these figures have been updated to Wednesday 8 December.
Vaccination figures: 6 January – 12 December 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 49 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,675 | 66,963 | 135,638 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,179 | 186,895 | 377,074 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,797 | 373,351 | 752,148 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,553 | 566,367 | 1,141,920 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 863,094 | 841,074 | 1,704,168 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 804,701 | 776,312 | 1,581,013 |
GGD | 61-65 | 1956-1960 | 148,600 | 159,019 | 307,619 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,034,447 | 967,870 | 2,002,317 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,047,054 | 766,918 | 1,813,972 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 900,243 | 814,668 | 1,714,911 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 791,724 | 661,199 | 1,452,923 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 768,234 | 673,957 | 1,442,191 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 778,273 | 667,174 | 1,445,447 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 762,719 | 622,990 | 1,385,709 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,235,519 | 895,260 | 2,130,779 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 778,400 | 675,977 | 1,454,377 |
GGD | Unknown | Unknown | 3,913 | 2,897 | 6,810 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,296,879 | 11,290,609 | 24,587,488 |
7 December 2021| 7:30 PM
Vaccination figures: 29 November to 5 December 2021
By Sunday 5 December, it is estimated that more than 24.4 million vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.1 million were second vaccinations. It is estimated that 88.7% of all people over 18 have received at least one vaccination, and 85.2% are fully vaccinated. According to estimates, 86.9% of all people over 12 years old have now received at least one vaccination, and 83.4% are fully vaccinated.
Booster vaccination and third vaccination for people with severely impaired immunity
RIVM started sending invitations to make an appointment for a COVID-19 booster vaccination from 18 November on. So far, more than 81,800 people have received their booster vaccination from the Municipal Public Health Services (GGDs). Between 18 and 30 November 2021, another 508,000 vaccine doses were distributed to hospitals and institutions that provide medical services. Most of these will be used for a booster vaccination.
Since 6 October 2021, more than 111,800 people with severely impaired immunity have received their third vaccination from the GGD.
Turnout and vaccination coverage
Vaccination turnout and vaccination coverage increased by a maximum of 1% in a number of age groups. Turnout for a first vaccination among young people was somewhat lower last week than in the previous weeks: more than 7,800 among people aged 12-17 years and more than 6,300 among people aged 18-25 years. The number of people who were fully vaccinated increased by more than 13,000 in both age groups in the past week.
Vaccination figures: 6 January – 5 December 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 48 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,633 | 66,900 | 135,533 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,096 | 186,737 | 376,833 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,694 | 373,064 | 751,758 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,452 | 565,986 | 1,141,438 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 862,940 | 840,378 | 1,703,318 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 804,447 | 775,441 | 1,579,888 |
GGD | 61-65 | 1956-1960 | 148,227 | 157,922 | 306,149 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,033,938 | 965,975 | 1,999,913 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,046,355 | 764,570 | 1,810,925 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 899,400 | 811,786 | 1,711,186 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 790,718 | 658,003 | 1,448,721 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 766,824 | 669,596 | 1,436,420 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 776,125 | 661,362 | 1,437,487 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 760,299 | 616,279 | 1,376,578 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,232,006 | 883,546 | 2,115,552 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 773,793 | 664,475 | 1,438,268 |
GGD | Unknown | Unknown | 3,676 | 2,672 | 6,348 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,278,377 | 11,236,410 | 24,514,787 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 47, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 643,122 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 48, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 87.0% | 83.7% |
18 years and older | 2003 and before | 88.8% | 85.5% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 48, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
30 November 2021| 4:30 PM
Vaccination figures: 22 to 28 November 2021
By Sunday 28 November, it is estimated that more than 24.4 million vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.1 million were second vaccinations. It is estimated that 88.7% of all people over 18 have received at least one vaccination, and 85.2% are fully vaccinated. According to estimates, 86.9% of all people over 12 years old have now received at least one vaccination, and 83.4% are fully vaccinated.
Booster vaccination and third vaccination for people with severely impaired immunity
RIVM started sending invitations to make an appointment for a COVID-19 booster vaccination from 18 November on. So far, more than 81,800 people have received their booster vaccination from the Municipal Public Health Services (GGDs). Between 18 and 30 November 2021, another 508,000 vaccine doses were distributed to hospitals and institutions that provide medical services. Most of these will be used for a booster vaccination.
Since 6 October 2021, more than 111,800 people with severely impaired immunity have received their third vaccination from the GGD.
Turnout and vaccination coverage
Vaccination turnout and vaccination coverage increased by a maximum of 1% in a number of age groups. Turnout for a first vaccination among young people was somewhat lower last week than in the previous weeks: more than 7,800 among people aged 12-17 years and more than 6,300 among people aged 18-25 years. The number of people who were fully vaccinated increased by more than 13,000 in both age groups in the past week.
Vaccination figures: 6 January – 28 November 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 47 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,597 | 66,840 | 135,437 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 190,001 | 186,555 | 376,556 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,576 | 372,809 | 751.385 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,259 | 565,600 | 1,140,859 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 862,611 | 839,604 | 1,702,215 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 804,082 | 774,386 | 1,578,468 |
GGD | 61-65 | 1956-1960 | 147,627 | 156,584 | 304,211 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,033,198 | 963,891 | 1,997,089 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,045,337 | 762,086 | 1,807,423 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 898,251 | 808,545 | 1,706,796 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 789,326 | 654,551 | 1,443,877 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 764,841 | 665,036 | 1,429,877 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 773,170 | 655,188 | 1,428,358 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 757,059 | 609,317 | 1,366,376 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,227,584 | 871,753 | 2,099,337 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 767,870 | 651,802 | 1,419.672 |
GGD | Unknown | Unknown | 3,532 | 2,535 | 6,067 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,525 | 482,801 | 1,423,326 | ||
Total6 | 13,253,675 | 11,178,800 | 24,432,475 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 47, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,356 estimated vaccinations administered by other vaccinators, and 641,562 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 46, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 86.7% | 83.0% |
18 years and older | 2003 and before | 88.5% | 84.9% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 47, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
23 November 2021| 4:50 PM
Vaccination figures: 15 to 21 November 2021
By Sunday 21 November, it is estimated that more than 24.3 million vaccinations had been administered in the Netherlands. More than 13.2 million of those were first vaccinations, and more than 11.1 million were second vaccinations. It is estimated that 88.5% of all people over 18 have received at least one vaccination, and 84.9% are fully vaccinated. According to estimates, 86.7% of all people over 12 years old have now received at least one vaccination, and 83.0% are fully vaccinated.
Turnout and vaccination coverage
Vaccination turnout and vaccination coverage increased by a maximum of 1% in a number of age groups.
The number of first vaccinations rose by more than 11,000 among people aged 12-17 years and more than 10,000 among people aged 18-25 years. The number of people who were fully vaccinated rose by more than 11,500 in both age groups.
The graph below shows the turnout for a first vaccination by week per 100,000 inhabitants from 27 September to 21 November 2021. Turnout for a first vaccination decreased last week compared to the weeks before that.
Third vaccination for people with severely impaired immunity
As of 2 November 2021, the weekly report includes an update on the numbers of third vaccinations given to people with severely impaired immunity from 6 October on. So far, more than 102,200 people from this group have received their third vaccination from the Municipal Public Health Services (GGDs).
Vaccination figures: 6 January – 21 November 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 46 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,557 | 66,774 | 135,331 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,896 | 186,422 | 376,318 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,379 | 372,561 | 750,940 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 575,031 | 565,218 | 1,140,249 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 862,254 | 838,891 | 1,701,145 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 803,666 | 773,435 | 1,577,101 |
GGD | 61-65 | 1956-1960 | 146,932 | 155,259 | 302,191 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,032,224 | 961,768 | 1,993,992 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,043,956 | 759,450 | 1,803,406 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 896,590 | 805,298 | 1,701,888 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 787,327 | 650,950 | 1,438,277 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 762,000 | 660,423 | 1,422,423 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 769,383 | 649,135 | 1,418,518 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 753,049 | 602,661 | 1,355,710 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,221,285 | 860,724 | 2,082,009 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 760,039 | 639,540 | 1,399,579 |
GGD | Unknown | Unknown | 3,413 | 2,417 | 5,830 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,519 | 482,783 | 1,423,302 | ||
Total6 | 13,220,729 | 11,122,626 | 24,343,355 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 46, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,350 estimated vaccinations administered by other vaccinators, and 639,376 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 46, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 86.7% | 83.0% |
18 years and older | 2003 and before | 88.5% | 84.9% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 46, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
16 November 2021| 4:15 PM
Vaccination figures: 8 to 14 November 2021
By Sunday 14 November, it is estimated that more than 24.2 million vaccinations had been administered in the Netherlands. More than 13.1 million of those were first vaccinations, and more than 11 million were second vaccinations. It is estimated that 88.3% of all people over 18 have received at least one vaccination, and 84.7% are fully vaccinated. According to estimates, 86.4% of all people over 12 years old have now received at least one vaccination, and 82.7% are fully vaccinated.
Minor increase in turnout
Once again, a minor increase can be observed in vaccination turnout in various age groups. The increase is 1% per age group at most.
The number of people who received a first vaccination rose by more than 14,000 in two age groups: 12-17 years and 18-25 years. The number of people who were fully vaccinated rose by more than 12,000 in both age groups.
The graph below shows the turnout for a first vaccination per 100,000 inhabitants from 27 September to 14 November 2021. The highest relative increase is in the age group of 12-17 years.
Third vaccination for people with severely impaired immunity
As of a few weeks ago, the weekly report includes an update on the numbers of third vaccinations given to people with severely impaired immunity. So far, over 89,000 people from this group have received their third vaccination from the Municipal Public Health Services (GGDs).
Vaccination figures: 6 January – 14 November 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 45 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,499 | 66,733 | 135,232 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,767 | 186,311 | 376,078 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 378,167 | 372,345 | 750,512 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 574,739 | 564,881 | 1,139,620 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 861,842 | 838,295 | 1,700,137 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 803,066 | 772,667 | 1,575,733 |
GGD | 61-65 | 1956-1960 | 146,055 | 154,128 | 300,183 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,030,857 | 959,923 | 1,990,780 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,042,058 | 757,229 | 1,799,287 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 894,157 | 802,597 | 1,696,754 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 784,373 | 648,154 | 1,432,527 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 757,867 | 656,960 | 1,414,827 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 763,570 | 644,641 | 1,408,211 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 746,627 | 597,596 | 1,344,223 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,211,058 | 851,836 | 2,062,894 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 748,681 | 629,646 | 1,378,327 |
GGD | Unknown | Unknown | 3,347 | 2,379 | 5,726 | |
GPs (estimated)3,4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,4,6 | 6 January 2021 | 940,454 | 482,551 | 1,423,005 | ||
Total6 | 13,171,413 | 11,077,789 | 24,249,202 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 45, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 9 November 2021.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. More information about the data used to estimate the number of vaccinations administered and the distribution of the first and second doses can be found in the update published on 9 November 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
Vaccinations within the framework of an extra vaccination for people with severely impaired immunity are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are displayed in Figure 1. No distinction can be made between these extra doses and the first and second dose; these doses were therefore included in the estimates for GPs and other vaccinators for weeks 40-45. This will have a minimal impact.
It is assumed that no more first or second doses of vaccine will be administered by other vaccinators after 11 November 2021.
The reason for this is that the number of first and second doses are based on the number of vaccines sent out for delivery, with no distinction made between vaccines used for the primary course of vaccination and for the booster campaign. - 222,285 estimated vaccinations administered by other vaccinators, and 636,346 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 45, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 86,4% | 82,7% |
18 years and older | 2003 and before | 88,3% | 84,7% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 and 4 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
9 November 2021| 4:00 PM
Vaccination figures: 1 to 7 November 2021
By Sunday 7 November, it is estimated that more than 24.1 million vaccinations had been administered in the Netherlands. More than 13 million of those were first vaccinations, and more than 11 million were second vaccinations. It is estimated that 87.9% of all people over 18 have received at least one vaccination, and 84.4% are fully vaccinated. According to estimates, 85.9% of all people over 12 years old have now received at least one vaccination, and 82.4% are fully vaccinated.
Minor increase in turnout for first and second vaccination
A minor increase can be observed in turnout and vaccination coverage in various age groups. The increase is 1% per age group at most.
The number of children aged 12-17 years who received a first vaccination last week increased by 14,000. More than 11,000 children in this age group reached full vaccination. Among young people aged 18-25 years, the number of first vaccinations increased by more than 14,000, and more than 13,000 reached full vaccination.
The graph below shows the turnout for a first vaccination per 100,000 inhabitants in recent weeks. It shows that turnout has been rising in most age groups since week 41. The highest relative increase is in the age groups of 12-17 and 18-25 years.
Third vaccination for people with severely impaired immunity
As of a few weeks ago, the weekly report includes an update on the numbers of third vaccinations given to people with severely impaired immunity. So far, over 75,000 people from this group have received their third vaccination from the Municipal Public Health Services (GGDs).
Vaccination figures: 6 January – 7 November 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 44 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,457 | 66,693 | 135,150 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,639 | 186,226 | 375,685 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 377,934 | 372,176 | 750,110 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 574,411 | 564,616 | 1,139,027 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 861,338 | 837,812 | 1,699,150 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 801,395 | 772,035 | 1,574,430 |
GGD | 61-65 | 1956-1960 | 144,875 | 153,136 | 298,011 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,029,080 | 958,260 | 1,987,340 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,039,577 | 755,056 | 1,794,633 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 891,055 | 800,027 | 1,691,082 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 780,198 | 645,607 | 1,425,805 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 751,921 | 653,816 | 1,405,737 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 755,381 | 640,577 | 1,395,958 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 737,537 | 592,908 | 1,330,445 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,196,805 | 843,604 | 2,040,409 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 733,914 | 619,530 | 1,353,444 |
GGD | Unknown | Unknown | 3,253 | 2,326 | 5,579 | |
GPs (estimated)4,5,8 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,6,8 | 6 January 2021 | 940,324 | 481,006 | 1,421,330 | ||
Total7 | 13,104,323 | 11,034,328 | 24,138,651 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 44, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021.
The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021).
People born in 1955, 1954 and 1953 could also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960.
Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. - Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated continuously as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 222,155 estimated vaccinations administered by other vaccinators, and 631,650 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
- The vaccinations within the framework of an extra vaccination for people with a severe immune disorder are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are reported separately.
A limited number of vaccinations are administered by other vaccinators from week 40 on. However, no distinction can be made between these extra doses and the first and second dose; these doses are therefore included in the estimates for GPs and other vaccinators. The impact of this will be limited.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 44, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 85.9% | 82.4% |
18 years and older | 2003 and before | 87.9% | 84.4% |
Footnotes:
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 44, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
2 November 2021| 4:00 PM
Vaccination figures: 25 to 31 October 2021
By Sunday 31 October, it is estimated that about 24 million vaccinations had been administered in the Netherlands. More than 13 million of those were first vaccinations and nearly 11 million were second vaccinations. It is estimated that 87.5% of all people over 18 have received at least one vaccination and 84.1% are fully vaccinated. 85.4% of all people over 12 years old have received at least one vaccination, and 82.1% are fully vaccinated.
Third vaccination for people with impaired immunity
A new addition to the weekly update are the numbers of third vaccinations given to people with impaired immunity. In October, a specific group of people with severely impaired immunity (immunocompromised people) were invited for a third vaccination against COVID-19. More than 61,700 people in this group have received their third vaccinations from the GGD so far.
Most vaccinations in youngest age groups
A slight increase can still be observed in turnout and vaccination coverage. An increase of no more than 1% was observed in most age groups. The strongest increase in vaccinations is still seen in the youngest age groups.
About 10,100 children aged 12-17 years received a first vaccination last week. More than 15,000 children in this age group reached full vaccination. Among people aged 18-25 years, about 7,900 received a first vaccination, and more than 12,400 reached full vaccination. First and second vaccinations continue to be administered in the age groups above 25 years old, but the increase in these age groups is smaller.
Vaccination figures: 6 January – 31 October 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 43 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,404 | 66,669 | 135,073 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,516 | 186,155 | 375,671 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 377,659 | 372,009 | 749,668 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 574,035 | 564,380 | 1,138,415 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 860,757 | 837,358 | 1,698,115 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 801,612 | 771,434 | 1,573,046 |
GGD | 61-65 | 1956-1960 | 143,536 | 152,211 | 295,747 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,027,057 | 956,880 | 1,983,937 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,036,678 | 753,299 | 1,789,977 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 887,266 | 797,859 | 1,685,125 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 775,454 | 643,237 | 1,418,691 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 745,282 | 650,478 | 1,395,760 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 746,526 | 636,285 | 1,382,811 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 727,885 | 588,081 | 1,315,966 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,182,183 | 835,277 | 2,017,460 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 719,787 | 610,178 | 1,329,965 |
GGD | Unknown | Unknown | 3,177 | 2,276 | 5,453 | |
GPs (estimated)4,5,8 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,6,8 | 6 January 2021 | 940,275 | 480,840 | 1,421,115 | ||
Total7 | 13,033,318 | 10,993,823 | 24,027,141 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 42, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021.
The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021).
People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960.
Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. - Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 222,106 estimated vaccinations administered by other vaccinators, and 623,207 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
- The vaccinations within the framework of an extra vaccination for people with a severe immune disorder are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are reported separately.
A limited number of vaccinations are administered by other vaccinators from week 40 on. However, no distinction can be made between these extra doses and the first and second dose; these doses are therefore included in the estimates for GPs and other vaccinators. The impact of this will be limited.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 43, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 85.4% | 82.1% |
18 years and older | 2003 and before | 87.5% | 84.1% |
Footnotes table 2:
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 43, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators (see footnote 3 for table 1), denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 2 and 3 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
26 October 2021| 4:30 PM
Vaccination figures: 18 to 24 October 2021
By Sunday 24 October, it is estimated that more than 23.9 million vaccinations had been administered in the Netherlands. Nearly 13 million of those were first vaccinations, and more than 10.9 million were second vaccinations. It is estimated that 87.2% of all people over 18 have received at least one vaccination. 85.2% of all people over 12 years old have received at least one vaccination, and 81.7% are fully vaccinated.
Most vaccinations in youngest age groups
A slight increase can still be observed in turnout and vaccination coverage. An increase of less than 1% was observed in most age groups. The strongest increase in vaccinations is in the youngest age groups.
About 10,500 children aged 12-17 years received a first vaccination last week. More than 16,700 children in this age group reached full vaccination. Among young people aged 18-25 years, about 6,300 received a first vaccination, and about 11,800 reached full vaccination. First vaccinations continue to be administered in the age groups above 25 years old, but the increase in these age groups is smaller.
Vaccination figures: 6 January – 24 October 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 42 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,365 | 66,636 | 135,001 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,420 | 186,071 | 375,491 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 377,460 | 371,833 | 749,293 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 573,685 | 564,110 | 1,137,795 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 860,241 | 836,905 | 1,697,146 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 801,026 | 770,806 | 1,571,832 |
GGD | 61-65 | 1956-1960 | 142,550 | 151,241 | 293,791 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,025,598 | 955,433 | 1,981,031 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,034,614 | 751,384 | 1,785,998 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 884,866 | 795,456 | 1,680,322 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 772,582 | 640,362 | 1,412,944 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 741,441 | 646,819 | 1,388,260 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 741,352 | 631,157 | 1,372,509 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 722,427 | 582,348 | 1,304,775 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,174,221 | 825,625 | 1,999,846 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 709,636 | 596,615 | 1,306,251 |
GGD | Unknown | Unknown | 3,140 | 2,253 | 5,393 | |
GPs (estimated)4,5,8 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,6,8 | 6 January 2021 | 940,269 | 480,799 | 1,421,068 | ||
Total7 | 12,989,122 | 10,944,770 | 23,933,892 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 42, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- 2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021.
The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021).
People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960.
Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. - Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVMNational Institute for Public Health and the Environment is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 222,100 estimated vaccinations administered by other vaccinators, and 618,621 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
- The vaccinations within the framework of an extra vaccination for people with a severe immune disorder are primarily administered by the Municipal Public Health Services (GGDs). These vaccinations are reported separately.
A limited number of vaccinations are administered by other vaccinators from week 40 on. However, no distinction can be made between these extra doses and the first and second dose; these doses are therefore included in the estimates for GPs and other vaccinators.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 42, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 85.2% | 81.7% |
18 years and older | 2003 and before | 87.2% | 83.8% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 42, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- 4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
19 October 2021| 4:00 PM
Vaccination figures: 11 to 17 October 2021
By Sunday 17 October, it is estimated that more than 23.8 million vaccinations had been administered in the Netherlands. More than 12.9 million of those were first vaccinations, and more than 10.8 million were second vaccinations. It is estimated that 87.1% of all people over 18 have received at least one vaccination, and 83.5% are fully vaccinated. Looking at all people aged 12 years and older, 84.9% have received at least one vaccination, and 81.4% are fully vaccinated.
Slight increase in turnout and vaccination coverage
A slight increase can still be observed in turnout and vaccination coverage. An increase of less than 1% was observed in most age groups. In the age group of 12-17 years, the increase for a first vaccination was 1%, while the increase in full vaccination was 2%.
Most vaccinations in youngest age groups
More than 8,400 children aged 12-17 years received a first vaccination last week. 18,200 children in this age group reached full vaccination. Among young people aged 18-25 years, more than 6,400 received a first vaccination, and about 13,000 reached full vaccination. Vaccinations continue to be administered in the age groups above 25 years old, but the increase in these age groups is smaller.
Vaccination figures: 6 January – 17 October 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 41 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,334 | 66,607 | 134,941 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,346 | 185,982 | 375,328 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 377,319 | 371,642 | 748,961 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 573,493 | 563,820 | 1,137,313 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 859,930 | 836,469 | 1,696,399 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 800,593 | 770,238 | 1,570,831 |
GGD | 61-65 | 1956-1960 | 141,890 | 150,295 | 292,185 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,024,620 | 954,025 | 1,978,645 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,033,238 | 749,519 | 1,782,757 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 883,082 | 793,165 | 1,676,247 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 770,603 | 637,718 | 1,408,321 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 738,766 | 643,081 | 1,381,847 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 737,615 | 626,020 | 1,363,635 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 718,331 | 576,596 | 1,294,927 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,167,830 | 815,991 | 1,983,821 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 699,011 | 581,419 | 1,280,430 |
GGD | Unknown | Unknown | 3,120 | 2,233 | 5,353 | |
GPs (estimated)4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,6 | 6 January 2021 | 940,106 | 480,556 | 1,420,662 | ||
Total7 | 12,953,456 | 10,894,293 | 23,847,749 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 41, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- 2. The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021.
The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021).
People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960.
Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. - Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 221,937 estimated vaccinations administered by other vaccinators, and 615,278 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 41, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 84.9% | 81.4% |
18 years and older | 2003 and before | 87.1% | 83.5% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 41, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- 4. The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over.
In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group.
The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS are displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older. - Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
12 October 2021| 4:45 PM
Vaccination figures: 4 to 10 October 2021
By Sunday 10 October, it is estimated that more than 23.7 million vaccinations had been administered in the Netherlands. More than 12.9 million of those were first vaccinations, and more than 10.8 million were second vaccinations. It is estimated that 86.9% of all people over 18 have received at least one vaccination, and 83.2% are fully vaccinated. Looking at all people aged 12 years and older, 84.7% have received at least one vaccination, and 80.9% are fully vaccinated.
Slight increase in turnout and vaccination coverage
A slight increase can still be observed in turnout and vaccination coverage. An increase of less than 1% was observed in most age groups over the past week. In the age group of 12-17 years, the increase for a first vaccination was 1%, while the increase in full vaccination was 2%.
Looking at the increase in absolute numbers, the largest increase occurred in the youngest age groups. More than 11,000 children aged 12-17 years received a first vaccination last week, and 21,000 reached full vaccination. Among young people aged 18-25 years, more than 9,000 received a first vaccination, and 14,500 reached full vaccination. New vaccinations continue to be administered in the age groups above 25 years old, but in smaller numbers.
Vaccination figures: 6 January – 10 October 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 40 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,315 | 66,572 | 134,887 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,284 | 185,903 | 375,187 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 377,185 | 371,429 | 748,614 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 573,294 | 563,518 | 1,136,812 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 859,650 | 835,989 | 1,695,639 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 800,279 | 769,579 | 1,569,858 |
GGD | 61-65 | 1956-1960 | 141,324 | 149,179 | 290,503 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,023,748 | 952,458 | 1,976,206 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,031,972 | 747,406 | 1,779,378 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 881,455 | 790,586 | 1,672,041 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 768,757 | 634,642 | 1,403,399 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 736,124 | 638,921 | 1,375,045 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 734,066 | 620,373 | 1,354,439 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 714,100 | 570,412 | 1,284,512 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,161,149 | 805,387 | 1,966,536 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 690,275 | 564,367 | 1,254,642 |
GGD | Unknown | Unknown | 3,108 | 2,227 | 5,335 | |
GPs (estimated)4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,6 | 6 January 2021 | 939,809 | 479,378 | 1,419,187 | ||
Total7 | 12,920,123 | 10,837,243 | 23,757,366 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 40, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 221,640 estimated vaccinations administered by other vaccinators, and 611,333 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 40, 20211-6
Age group | Birth years | Turnout for at least one dose | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 84.7% | 80.9% |
18 years and older | 2003 and before | 86.9% | 83.2% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 40, 20211-6
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
- Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
05 October 2021| 4:45 PM
Vaccination figures: 26 September to 3 October 2021
By Sunday 3 October, it is estimated that more than 23.6 million vaccinations had been administered in the Netherlands. More than 12.8 million of those were first vaccinations, and more than 10.7 million were second vaccinations. It is estimated that 86.7% of all people over 18 have received at least one vaccination, and 82.9% are fully vaccinated. Looking at all people aged 12 years and older, 84.4% have received at least one vaccination, and 80.5% are fully vaccinated.
Slight increase in turnout and vaccination coverage
A slight increase can still be observed in turnout and vaccination coverage. Most age groups show an increase of less than 1%. In the age group of 12-17 years, the increase is between 1 and 2%.
See the tabels and footnotes in this pdf (in Dutch)
28 September 2021| 4:00 PM
Vaccination figures: 20 to 26 September 2021
By Sunday 26 September, it is estimated that more than 23.5 million vaccinations had been administered in the Netherlands. More than 12.8 million of those were first vaccinations, and more than 10.7 million were second vaccinations. It is estimated that 86.3% of all people over 18 have received a first vaccination, and 82.4% are fully vaccinated. Looking at all people over 12 years old, 84.0% have received a first vaccination, and 80.0% are fully vaccinated.
Slight increase in turnout and vaccination coverage
A slight increase can still be observed in turnout and vaccination coverage. For most age groups, the increase is about 1%. Full vaccination coverage increased by 2% among the age group of 12-17 years.
Vaccination maps by municipality provide more detail
As of this week, turnout and full vaccination coverage among people aged 12-17 years and all people over 12 can now be displayed by municipality. This completes the overviews of vaccinated age groups by municipality.
Vaccination figures: 6 January – 26 September 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 38 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose3 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,249 | 66,509 | 134,758 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,137 | 185,739 | 374,876 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 376,864 | 371,083 | 747,947 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 572,849 | 562,964 | 1,135,813 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 858,976 | 835,046 | 1,694,022 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 799,370 | 768,377 | 1,567,747 |
GGD | 61-65 | 1956-1960 | 139,759 | 146,953 | 286,712 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,021,410 | 949,325 | 1,970,735 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,028,484 | 743,090 | 1,771,574 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 876,918 | 785,099 | 1,662,017 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 763,198 | 628,374 | 1,391,572 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 728,545 | 630,187 | 1,358,732 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 723,272 | 608,867 | 1,332,139 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 701,794 | 557,766 | 1,259,560 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,139,248 | 782,641 | 1,921,889 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 661,617 | 527,039 | 1,188,656 |
GGD | Unknown | Unknown | 2,994 | 2,147 | 5,141 | |
GPs (estimated)4,5 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,6 | 6 January 2021 | 932,493 | 472,664 | 1,405,157 | ||
Total7 | 12,811,406 | 10,712,787 | 23,524,193 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 38, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 214,114 estimated vaccinations administered by other vaccinators, and 600,840 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 38, 20211-8
Age group | Birth years | Vaccination turnout | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 84.0% | 80.0% |
18 years and older | 2003 and before | 86.3% | 82.4% |
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 38, 20211-8
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- From 14 September 2021 on, this table includes previous COVID-19 infection in calculating vaccination coverage. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, Table 2 will also count these people among the group of people who are fully vaccinated.
- Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
21 September 2021| 6:00 PM
Vaccination figures: 13–19 September 2021
By Sunday 19 September, it is estimated that 23.4 million vaccinations had been administered in the Netherlands. More than 12.7 million of those were first vaccinations, and more than 10.6 million were second vaccinations. It is estimated that 86.0% of all people over 18 have received a first vaccination, and 82.1% are fully vaccinated. Looking at all people over 12 years old, 83.5% have received a first vaccination, and 79.6% are fully vaccinated.
More vaccinations were administered in the past week than in the previous few weeks, especially in the younger age groups. As a result, turnout for the first vaccination rose more sharply than in recent weeks.
Vaccinations after COVID-19 infection now included in vaccination coverage by age and municipality
Last week’s update noted that people who have received one vaccination after previously having had COVID-19 will be included in the fully vaccinated category in the national figures from now on. From this week on, these people will also be included in the fully vaccinated category in the breakdown of vaccination coverage by age and municipality.
Data corrections
The update for this week contains two corrections resulting from ongoing improvements in how source data is processed. A quality check revealed that some vaccinations with the Janssen vaccine had previously been over-counted in calculating vaccination coverage by age group. As a result, vaccination coverage by age was overestimated slightly (by 0.9%). In contrast, on the maps showing vaccination coverage by municipality, vaccination coverage at the municipal level was underestimated (by 4.2% on average).
Vaccination figures: 6 January – 19 September 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 37 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose7 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,217 | 66,470 | 134,687 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,028 | 185,636 | 374,664 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 376,648 | 370,891 | 747,539 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 572,514 | 562,675 | 1,135,189 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 858,543 | 834,495 | 1,693,038 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 798,747 | 767,621 | 1,566,368 |
GGD | 61-65 | 1956-1960 | 138,742 | 145,588 | 284,330 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,019,876 | 947,475 | 1,967,351 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,026,248 | 740,401 | 1,766,649 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 874,095 | 781,822 | 1,655,917 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 759,870 | 624,575 | 1,384,445 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 723,833 | 624,977 | 1,348,810 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 716,833 | 601,918 | 1,318,751 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 694,495 | 550,336 | 1,244,831 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,126,531 | 769,223 | 1,895,754 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 642,738 | 505,691 | 1,148,429 |
GGD | Unknown | Unknown | 2,950 | 2,127 | 5,077 | |
GPs (estimated)3,4 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,5 | 6 January 2021 | 925,061 | 495,038 | 1,420,099 | ||
Total6 | 12,741,198 | 10,665,876 | 23,407,074 |
Explanation of target group and figures, in table vaccination figures
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 37, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 594,784 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 37, 20211-7
Age group | Birth years | Vaccination turnout | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 83.5% | 79.6% |
18 years and older | 2003 and before | 86.0% | 82.1% |
Explanation
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 37, 20211-8
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- From 14 September 2021 on, this table includes figures for people who previously had COVID-19 in calculating vaccination coverage. As a result, the vaccination coverage reported in this table for 18 years and older may differ from the figures as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
- People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
- Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. From 14 September 2021 on, these people will also be counted among the group of people who are fully vaccinated.
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
14 September 2021| 6:30 PM
For an explanation of the weekly COVID-19 figures in the Netherlands, read the news: People who had one jab after having COVID-19 now included in vaccination coverage figures for full vaccination
Vaccination figures: 6 January – 12 September 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 36 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose7 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,194 | 66,435 | 134,629 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 188,957 | 185,551 | 374,508 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 376,470 | 370,712 | 747,182 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 572,286 | 562,365 | 1,134,651 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 858,103 | 833,945 | 1,692,048 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 798,171 | 766,847 | 1,565,018 |
GGD | 61-65 | 1956-1960 | 137,718 | 144,035 | 281,753 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,018,326 | 945,542 | 1,963,868 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,023,986 | 737,558 | 1,761,544 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 871,221 | 778,144 | 1,649,365 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 756,393 | 620,658 | 1,377,051 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 719,037 | 619,380 | 1,338,417 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 709,974 | 594,419 | 1,304,393 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 686,663 | 542,111 | 1,228,774 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,112,166 | 753,810 | 1,865,976 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 621,582 | 479,543 | 1,101,125 |
GGD | Unknown | Unknown | 2,713 | 1,963 | 4,676 | |
GPs (estimated)3,4 | 15 February 2021 | 1,226,229 | 1,088,917 | 2,315,146 | ||
Other vaccinators (estimated)3,5 | 6 January 2021 | 925,061 | 493,696 | 1,418,757 | ||
Total6 | 12,673,250 | 10,585,631 | 23,258,881 |
Explanation of target group and figures, in table vaccination figures
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 35, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 588,295 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 36, 20211-7
Age group | Birth years | Vaccination turnout | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 83.1% | 79.0% |
18 years and older | 2003 and before | 85.6% | 81.7% |
Explanation
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by age, Statistics Netherlands (CBS), January 2020.
- People under 80 years old who have already had COVID-19 will only need one dose of COVID-19 vaccine. People who only received a first vaccination from the GGD, other than the Janssen vaccine, and had received a positive COVID-19 test result from the GGD at least 8 weeks prior to vaccination and/or self-reported having had COVID-19, are included in the calculation of the vaccination coverage. As a result, the vaccination coverage in this table may differ from the percentage for 18 years and older as reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
- People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
- Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. Since our dataset currently does not include sufficient data on this, however, for the time being these people will be counted among the group of people who have been fully vaccinated (except for those who received the Janssen vaccine).
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.
The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. For the calculation of turnout and vaccination coverage in this table, the denominator is an estimate of the number of young people who will turn 12 years old in the current week.
7 September 2021| 4:23 PM
Vaccination figures: 30 August – 5 September 2021
By Sunday 5 September, it is estimated that more than 23.1 million vaccinations had been administered in the Netherlands. More than 12.6 million of those were first vaccinations, and more than 10.5 million were second vaccinations. It is estimated that 85.4% of all people over 18 have received a first vaccination by now, and 77.1% are fully vaccinated. Looking at all people over 12 years old, 83.1% have received a first vaccination, and 74.3% are fully vaccinated.
Turnout for first vaccination
The RIVM vaccination update shows that turnout for a first vaccination has increased by 1%, but only in the age groups under 30 years old. It stayed the same in the age groups over 31 years old.
That does not mean that no more first vaccinations are being administered, since they still are. However, it takes approximately 150,000 vaccinations to increase vaccination turnout or coverage by 1% in all people over 12 years old. About 50,000 first vaccinations were administered this week.
Vaccination coverage
Vaccination coverage indicates what percentage of the population has been fully vaccinated.
Vaccination coverage among young people aged 12-17 increased by 7%, rising to 39%. Coverage is 41% if children born in 2009 who have not yet turned 12 are not included. Vaccination coverage among older age groups has also increased. Among people aged 18-25, vaccination coverage increased by 2%, rising to 57%, and vaccination coverage among people aged 25-65 increased by 1%.
People are currently considered fully vaccinated after receiving two vaccinations, or one vaccination with the Janssen vaccine. If a person has received one vaccination after previously having COVID-19, that person is also considered fully vaccinated. These people are currently counted in the category of ‘turnout for first vaccination’, because they have only received one vaccination. They are not yet counted in the category of ‘fully vaccinated’ because we cannot currently filter the data to sort these people out. We expect to be able to count these people as fully vaccinated in a report in the near future, which will result in a higher figure for vaccination coverage.
Vaccination figures: 6 January – 5 September 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 35 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose7 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,167 | 66,402 | 134,569 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 188,895 | 185,469 | 374,364 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 376,351 | 370,513 | 746,864 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 572,097 | 562,069 | 1,134,166 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 857,758 | 833,412 | 1,691,170 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 797,746 | 766,065 | 1,563,811 |
GGD | 61-65 | 1956-1960 | 137,023 | 142,544 | 279,567 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,017,202 | 943,645 | 1,960,847 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,022,351 | 774,521 | 1,756,908 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 869,131 | 774,521 | 1,643,652 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 753,875 | 616,792 | 1,370,667 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 715,663 | 614,072 | 1,329,735 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 705,465 | 586,817 | 1,292,282 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 681,830 | 533,418 | 1,215,248 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,102,904 | 737,915 | 1,840,819 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 605,307 | 450,715 | 1,056,112 |
GGD | Unknown | Unknown | 2,675 | 1,949 | 4,624 | |
GPs (estimated)3,4 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | ||
Other vaccinators (estimated)3,5 | 6 January 2021 | 925,625 | 493,637 | 1,419,262 | ||
Total6 | 12,628,782 | 10,503,429 | 23,132,211 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 35, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX were administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines were administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 585,133 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 35, 2021
Age group | Birth years | Vaccination turnout | Vaccination coverage (full vaccination) |
---|---|---|---|
12 years and older | 2009 and before | 83.1% | 74.3% |
18 years and older | 2003 and before | 85.4% | 77.1% |
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by birth year, Statistics Netherlands (CBS), January 2020.
- The turnout and vaccination coverage for 18 years and older reported here are also reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
- People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
- Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. Since our dataset currently does not include sufficient data on this, however, for the time being these people will be counted among the group of people who have been fully vaccinated (except for those who received the Janssen vaccine).
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.
The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. For the calculation of turnout and vaccination coverage in this table, the denominator is an estimate of the number of young people who will turn 12 years old in the current week.
31 August 2021 | 4:23 PM
Vaccination figures: 23 - 29 August 2021
By Sunday 29 August, it is estimated that more than 22.9 million vaccinations had been administered in the Netherlands. More than 12.5 million of those were first vaccinations, and more than 10.3 million were second vaccinations. It is estimated that 85.2% of all people over 18 have received a first vaccination by now, and 76.5% are fully vaccinated. Looking at all people over 12 years old, 82.8% have received a first vaccination, and 73.3% are fully vaccinated.
Turnout for first vaccination
The RIVM vaccination update shows that turnout for a first vaccination has increased somewhat in the age groups under 55 years old. 51% of all young people born in 2004 through 2009 have now received their first vaccination. Young people born in 2009 who have not yet turned 12 cannot make an appointment yet. If they are not included in the calculations, then vaccination turnout in the 12-17 age group is currently 54%.
Vaccination coverage
Vaccination coverage indicates what percentage of the population has been fully vaccinated.
Vaccination coverage among the youngest age group increased by 9%, rising to 32%. Coverage is 34% if children born in 2009 who have not yet turned 12 are not included. Vaccination coverage among older age groups has also increased.
People are currently considered fully vaccinated after receiving two vaccinations, or one vaccination with the Janssen vaccine. If a person has received one vaccination after previously having COVID-19, that person is fully vaccinated. These people are currently counted in the category of ‘turnout for first vaccination’. We expect to be able to count these people as fully vaccinated in a report in the near future.
Vaccination figures: 6 January – 29 August 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 34 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose7 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,147 | 66,357 | 134,504 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 188,822 | 185,357 | 374,179 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 376,227 | 370,240 | 746,467 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 571,888 | 561,594 | 1,133,482 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 857,439 | 832,553 | 1,689,992 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 797,323 | 764,860 | 1,562,183 |
GGD | 61-65 | 1956-1960 | 136,240 | 139,944 | 276,184 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,016,076 | 940,564 | 1,956,640 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,020,599 | 729,988 | 1,750,587 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 866,883 | 769,168 | 1,636,051 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 751,260 | 610,711 | 1,361,971 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 712,000 | 605,650 | 1,317,650 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 700,685 | 575,060 | 1,275,745 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 676,481 | 520,245 | 1,196,726 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,092,468 | 714,802 | 1,807,270 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 586,860 | 374,939 | 961,799 |
GGD | Unknown | Unknown | 2,638 | 1,921 | 4,559 | |
GPs (estimated)3,4 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | ||
Other vaccinators (estimated)3,5 | 6 January 2021 | 925,625 | 493,051 | 1,418,676 | ||
Total6 | 12,576,288 | 10,345,921 | 22,922,209 |
24 August 2021 | 5:36 PM
Vaccination figures: 16 – 22 August 2021
By Sunday 22 August, it is estimated that more than 22.6 million vaccinations had been administered in the Netherlands. More than 12.5 million of those were first vaccinations, and more than 10.1 million were second vaccinations. It is estimated that 84.9% of all people over 18 have received a first vaccination by now, and 75.7% are fully vaccinated. This week, these figures are also available for everyone over the age of 12. 82.4% of all people over 12 years old have received a first vaccination, and 72.0% are fully vaccinated.
Turnout for first vaccination
The RIVM vaccination update shows that turnout for a first vaccination is no longer increasing in most age groups. An increase can still be observed in the younger age groups. Nearly 49% of all young people born in 2004 through 2009 have now received their first vaccination. Young people born in 2009 who have not yet turned 12 cannot make an appointment yet. If they are not included in the calculations, then vaccination turnout in the 12-17 age group is currently 52%.
Vaccination coverage
Vaccination coverage indicates which age groups have received two vaccinations or one Janssen vaccination. Vaccination coverage among the younger age groups has continued to increase. The age group of 12-17 years has now achieved a vaccination coverage of more than 23%. Coverage is nearly 25% if children born in 2009 who have not yet turned 12 are not included. For people aged 18-25 years, vaccination coverage has increased to more than 52%, rising to 54% for people aged 26-30. In the age group of 30 years and older, vaccination coverage is still rising slightly or stabilising.
Turnout and vaccination coverage by municipality
Vaccination coverage by municipality is displayed according to people in various age groups who have received two vaccinations or one Janssen vaccination. The graph for vaccination coverage in the age group of 18-25 years has been added to this week’s update.
Vaccination figures: 6 January – 22 August 2021
Table 1: COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 33 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose7 | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,119 | 66,304 | 134,423 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 188,741 | 185,210 | 373,951 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 376,084 | 369,977 | 746,061 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 571,659 | 561,105 | 1,132,764 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 857,059 | 831,658 | 1,688,717 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 796,803 | 763,467 | 1,560,270 |
GGD | 61-65 | 1956-1960 | 135,322 | 136,897 | 272,219 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,014,679 | 937,184 | 1,951,863 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,018,528 | 725,403 | 1,743,931 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 864,316 | 763,301 | 1,627,617 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 748,162 | 604,149 | 1,352,311 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 707,652 | 596,004 | 1,303,656 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 694,952 | 561,882 | 1,256,834 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 670,142 | 505,562 | 1,175,704 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,081,831 | 686,825 | 1,768,656 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 561,747 | 268,403 | 830,150 |
GGD | Unknown | Unknown | 2,525 | 1,846 | 4,371 | |
GPs (estimated)3,4 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | ||
Other vaccinators (estimated)3,5 | 6 January 2021 | 925,625 | 488,375 | 1,414,000 | ||
Total6 | 12,512,573 | 10,142,469 | 22,655,042 |
Footnotes:
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The start date in the table refers to the start date of the oldest birth year within the birth cohort to which the start date refers. Information on start dates of groups of persons who were eligible for vaccination at a different time than other persons in their birth year, such as care workers, can be found in the update published on 10 August 2021. The people in this table who were born in 1956-1960 do not include the entire age group of people living at home, since the majority of those were vaccinated by their GP; these are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 may also be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated. The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday.
- Vaccination data for people who are vaccinated by their GP or by other vaccinators is registered in CIMS, the national registration system, if they give permission for their personal data to be registered. As a result, the number of vaccinations administered by GPs and other vaccinators and registered in CIMS does not provide a comprehensive overview. To obtain the most comprehensive overview possible of the number of vaccinations administered by GPs and other vaccinators, the number of doses issued to vaccination sites as ordered by RIVM is used to estimate the total number. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 578,547 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
- The number of vaccinations administered by the GGD listed under ‘Second dose’ may be higher than the number listed for the GGD under ‘First dose’. From 16 July 2021 on, it was possible to get the second vaccine dose from the GGD even if the first dose was administered by a different vaccinator.
Table 2: Estimated turnout and vaccination coverage for COVID-19 vaccination, week 1 to 33, 2021
Age group | Birth years | Vaccination turnout | Vaccination coverage |
---|---|---|---|
12 years and older | 2009 and before | 82.4% | 72.0% |
18 years and older | 2003 and before | 84.9% | 75.7% |
Explanation:
- Source: data provided by GGD GHOR Nederland from CoronIT, supplemented by the estimated number of first and second doses administered by GPs and other vaccinators, denominator label: number of people by birth year, Statistics Netherlands (CBS), January 2020.
- The turnout and vaccination coverage for 18 years and older reported here are also reported on the website of the European Centre for Disease Prevention and Control (ECDC).
- The term ‘turnout’ is used to indicate what percentage of the population has received at least one dose in a vaccination series. The term ‘vaccination coverage’ is used to indicate what percentage of the population is fully vaccinated.
- The turnout and vaccination coverage for 18 years and older also includes vaccinations of people aged 12 years and older administered by GPs and other vaccinators, because the number of vaccinations administered by these vaccinators has been estimated based on logistical data, in which it is not possible to sort the data by birth year. This is expected to be a small group of people and will not have a major effect on turnout and vaccination coverage for the group aged 18 and over. In addition, the persons in the group for which the age is unknown are included in the category of 12 years and older, since this concerns the entire population eligible for vaccination. The category of people aged 18 years and older does not include this entire group. The turnout and vaccination coverage for people aged 12-17 years based on registered vaccinations in CoronIT and CIMS is displayed in Figures 1 and 2 of this report. Due to the factors listed above, it is not possible to calculate the turnout and vaccination coverage by subtracting these figures for the group aged 18 years and older from the group aged 12 years and older.
- People who have been vaccinated by the GGD with the Janssen vaccine are included in both turnout and vaccination coverage, since this is a single-dose vaccine.
- Vaccinated persons who are not registered in the Personal Records Database (Basisregistratie Personen, BRP) are included in the numerator but not in the denominator in calculating the turnout and vaccination coverage. This applies for example to some of the homeless people, asylum-seekers, migrant workers and sailors. This means that the turnout is somewhat overestimated.
- People who have already had COVID-19 will only need one dose of COVID-19 vaccine. Since our dataset currently does not include sufficient data on this, however, for the time being these people will be counted among the group of people who have been fully vaccinated (except for those who received the Janssen vaccine).
- Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before being vaccinated.
- The entire group of young people born on or before 30 June 2009 were invited all at once. Young people born in or after July 2009 can make an appointment after their birthday. To calculate turnout and vaccination coverage in this table, the denominator is an estimate of the number of young people who will turn 12 years old in the current week.
17 August 2021 | 5:00 PM
Vaccination figures: 9– 15 August 2021
By Sunday 15 August, it is estimated that 22.3 million vaccinations had been administered in the Netherlands. More than 12.4 million of those were first vaccinations, and more than 9.9 million were second vaccinations. It is estimated that nearly 75% of all people over 18 have received full vaccination by now. About 85% have received their first vaccination.
Turnout for first vaccination
The RIVM National Institute for Public Health and the Environment vaccination update shows that turnout for a first vaccination is no longer increasing in most age groups. First vaccinations are still being added in each age group, but the number is small compared to the total. A minor increase can be observed in the youngest age groups. 46% of all young people born in 2004 through 2009 have now received their first vaccination. Young people born in 2009 who have not yet turned 12 cannot make an appointment yet. If they are not included in the calculations, then vaccination turnout in the 12-17 age group is currently 49%.
Vaccination coverage
Vaccination coverage indicates which age groups have received two vaccinations or one Janssen vaccination. Vaccination coverage among young people has continued to increase. The age group of 12-17 years has achieved a vaccination coverage of 14%. Coverage is 15% if children born in 2009 who have not yet turned 12 are not included. For people aged 18-25 years, vaccination coverage has increased to 49%, rising to 52% for people aged 26-30. Vaccination coverage also increased somewhat in the age group of 30-39 years. Among people aged 40 years and older, vaccination coverage has stabilised or is still increasing slightly.
Vaccination coverage by municipality
Vaccination coverage by municipality is displayed according to people in various age groups who have received two vaccinations or one Janssen vaccination. In the age group of 26-45 years, vaccination coverage primarily increased in the east and southeast of the Netherlands and in the Randstad conurbation. The increase in these areas is also reflected in vaccination coverage among people aged 18 years and older.
Vaccination figures: 6 January – 15 August 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 32 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and earlier | 26 January 2021 | 68,089 | 66,246 | 134,335 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 188,672 | 185,097 | 373,769 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 375,906 | 369,756 | 745,662 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 571,366 | 560,638 | 1,132,004 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 856,610 | 830,827 | 1,687,437 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 796,215 | 762,052 | 1,558,267 |
GGD | 61-65 | 1956-1960 | 134,149 | 133,271 | 267,420 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,013,072 | 934,077 | 1,947,149 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,016,102 | 720,892 | 1,736,994 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 861,340 | 757,520 | 1,618,860 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 744,854 | 597,128 | 1,341,982 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 702,983 | 584,925 | 1,287,908 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 688,462 | 545,639 | 1,234,101 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 663,199 | 485,128 | 1.148,327 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,070,400 | 640,717 | 1,711,117 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 532,599 | 165,636 | 698,235 |
GGD | Unknown | Unknown | 2,434 | 1,767 | 4,201 | |
GPs (estimated)4,5 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | ||
Other vaccinators (estimated)4,6 | 6 January 2021 | 925,625 | 488,108 | 1,413,733 | ||
Total7 | 12,440,704 | 9,918,341 | 22,359,045 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 32, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen® . One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinates care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), young people living at home who were born in 2003-2005 and who are in medical high-risk groups (from 18 May 2021), and people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age). The start date in the table refers to the birth year. On the Wadden Islands, vaccination started from 16 February 2021 for people born in 1941-1945 on the islands of Texel, Terschelling and Ameland, and for people born in 1941-1960 for the islands of Vlieland and Schiermonnikoog. From 25 May 2021, vaccination on the Wadden Islands was available for all people born in 2003 or before. People born in 1956-1960 were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they were also able to make an appointment for vaccination with COM/SPX via the GGD. The people in this table who were born in 1956-1960 are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1953-1955 may also have been vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. This group could decide for themselves whether they accepted the invitation from their GP or were vaccinated by the GGD. Finally, people living in a residential institution are sometimes also vaccinated by the GGD. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before receiving the vaccine. Young people born in July and August 2009 can make an appointment after their birthday; the strategy for September and beyond is not yet known.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery).For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 574,932 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
10 August 2021 | 17:30 PM
Vaccination figures: 2– 8 August 2021
By Sunday 8 August, it is estimated that 21.6 million vaccinations had been administered in the Netherlands. More than 12.3 million of those were first vaccinations, and more than 9.2 million were second vaccinations. It is estimated that more than 71% of all people over 18 have been fully vaccinated by now. Based on registered vaccinations, more than 84% of all people over 51 have been fully vaccinated, rising to 91% of all people aged 76-80 years.
Turnout among children, adolescents and young adults continues to rise
The 29th RIVM National Institute for Public Health and the Environment vaccination update shows that vaccination turnout in the age group of 12-17 years has continued to increase. By week 31, more than 43% of all young people born in 2004 through 2009 had received their first vaccination. Some of the young people born in 2009 cannot make an appointment yet, because they have not turned 12 yet. If this group is not included in the calculations, then vaccination turnout in the 12-17 age group is currently 47%. 64% of young adults aged 18-25 have received a first vaccination.
Vaccination turnout by municipality
The figure shows turnout by municipality among people aged 18 years and older who have received at least one vaccination. Regional differences in turnout are minor. In all age groups, vaccination turnout is slightly higher in the east and southeast of the country, and lower in several municipalities in the Dutch ‘Bible belt’ and in a few bigger cities.
Various corrections in the dataset
Several corrections have been made in the GGD GHOR dataset, and a correction has been made on the RIVM end ads well. For example, the heterologous vaccinations after AstraZeneca were not classified as first vaccinations but as second vaccinations, and cancelled appointments were removed from the GGD GHOR dataset. As a result, the number of vaccinations administered by the Municipal Public Health Services (GGDs) throughout the entire vaccination campaign was corrected on Friday 6 August. This involved approximately 160,000 vaccinations. This leads to minor changes in the figures for first and second vaccinations. Based on the updated dataset, over 84% of over-18s had received at least one vaccination by Sunday 8 August.
Vaccination figures: 6 January – 8 August 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 31 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date2 | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 en eerder | 26 January 2021 | 68,057 | 66,113 | 134,170 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 188,600 | 184,853 | 373,453 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 375,716 | 369,246 | 744,962 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 571,112 | 559,520 | 1,130,632 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 856,159 | 828,699 | 1,684,858 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 795,547 | 759,110 | 1,554,657 |
GGD | 61-65 | 1956-1960 | 132,921 | 125,112 | 258,033 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,011,263 | 926,896 | 1,938,159 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,013,472 | 709,106 | 1,722,578 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 858,167 | 740,902 | 1,599,069 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 741,450 | 576,268 | 1,317,718 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 698,033 | 550,041 | 1,248,074 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 681,111 | 488,483 | 1,169,594 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 655,415 | 391,412 | 1,046,827 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,058,635 | 366,233 | 1,424,868 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 501,760 | 54,244 | 556,004 |
GGD | Unknown | Unknown | 2,315 | 1,641 | 3,956 | |
GPs (estimated)4,5 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | ||
Other vaccinators (estimated)4,6 | 6 January 2021 | 925,625 | 483,251 | 1,408,876 | ||
Total7 | 12,363,985 | 9,270,047 | 21,634,032 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 31, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinates care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), young people living at home who were born in 2003-2005 and who are in medical high-risk groups (from 18 May 2021), and people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age). The start date in the table refers to the birth year. On the Wadden Islands, vaccination started from 16 February 2021 for people born in 1941-1945 on the islands of Texel, Terschelling and Ameland, and for people born in 1941-1960 for the islands of Vlieland and Schiermonnikoog. From 25 May 2021, vaccination on the Wadden Islands was available for all people born in 2003 or before. People born in 1956-1960 were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they were also able to make an appointment for vaccination with COM/SPX via the GGD. The people in this table who were born in 1956-1960 are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1953-1955 may also have been vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960. This group could decide for themselves whether they accepted the invitation from their GP or were vaccinated by the GGD. Finally, people living in a residential institution are sometimes also vaccinated by the GGD. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before receiving the vaccine. Young people born in July and August 2009 can make an appointment after their birthday; the strategy for September and beyond is not yet known.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery).For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 570,335 vaccinations administered by the GGD, involved JANSS.These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
4 August 2021 | 12:40 PM
Vaccination figures: 6 January – 3 August 2021
Read the news: Nearly 85% of people aged 18 and over have had at least one vaccination
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 30 (2021), by type of vaccinator.
Vaccinator | Target group | Birth year | Start date | First dose | Second dose | Total |
---|---|---|---|---|---|---|
GGD | 91+ | 1930 and before | 26 January 2021 | 68,467 | 66,007 | 134,474 |
GGD | 86-90 | 1931-1935 | 29 January 2021 | 189,653 | 184,756 | 374,409 |
GGD | 81-85 | 1936-1940 | 5 February 2021 | 377,546 | 368,854 | 746,400 |
GGD | 76-80 | 1941-1945 | 6 March 2021 | 574,250 | 558,204 | 1,132,454 |
GGD | 71-75 | 1946-1950 | 6 April 2021 | 861,649 | 826,667 | 1,688,316 |
GGD | 66-70 | 1951-1955 | 19 April 2021 | 802,114 | 756,009 | 1,558,123 |
GGD | 61-65 | 1956-1960 | 154,943 | 94,843 | 249,786 | |
GGD | 56-60 | 1961-1965 | 27 April 2021 | 1,026,950 | 924,052 | 1,951,002 |
GGD | 51-55 | 1966-1970 | 20 May 2021 | 1,024,370 | 697,107 | 1,721,477 |
GGD | 46-50 | 1971-1975 | 26 May 2021 | 869,515 | 720,141 | 1,589,656 |
GGD | 41-45 | 1976-1980 | 29 May 2021 | 748,325 | 541,554 | 1,289,879 |
GGD | 36-40 | 1981-1985 | 1 June 2021 | 702,005 | 472,974 | 1,174,979 |
GGD | 31-35 | 1986-1990 | 7 June 2021 | 679,484 | 332,499 | 1,011,983 |
GGD | 26-30 | 1991-1995 | 11 June 2021 | 648,597 | 189,851 | 838,448 |
GGD | 18-25 | 1996-2003 | 15 June 2021 | 1,051,459 | 219,439 | 1,270,898 |
GGD | 12-17 | 2004-2009 | 22 June 2021 | 462,014 | 17,748 | 479,762 |
GGD | Age unknown | birth year unknown | 2,461 | 1,613 | 4,074 | |
GPs | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | ||
Other vaccinators | 6 January 2021 | 925,625 | 482,411 | 1,408,036 | ||
Total | 12,398,054 | 8,543,646 | 20,941,700 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 30, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinate people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people living at home who were born in 2003-2005 (aged 16-18 years at that time). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 for people born in 1941-1945 (aged 75-79 years at that time) on the islands of Texel, Terschelling and Ameland, and for people born in 1941-1960 (aged 60-79 years at that time) for the islands of Vlieland and Schiermonnikoog). From 25 May 2021, vaccination on the Wadden Islands was available for all people born in 2003 or before (aged 18 years and over at that time). People born in 1956-1960 (aged 60-64 years at that time) were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they were also able to make an appointment for vaccination with COM/SPX via the GGD. The people in this table who were born in 1956-1960 (aged 60-64 years at that time) are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years at that time) also had the option to be vaccinated by their GP. This happened if the GP had supplies of the vaccine (VAX) left over after vaccinating people who were born in 1956-1960 (aged 60-64 years at that time). This group could decide for themselves whether they accepted the invitation from their GP or were vaccinated by the GGD. Finally, people living in a residential institution are sometimes also vaccinated by the GGD. Young people born in 2009 will not all be invited at the same time, as this group must turn 12 before receiving the vaccine. Young people born in July and August 2009 can make an appointment after their birthday; the strategy for September and beyond is not yet known.
- From 16 July 2021 on, people who have been vaccinated with VAX as a first dose will have the opportunity to be vaccinated with COM by the GGD for their second dose. This mainly involves people born in 1956-1960 (aged 61-65 years). As long as these vaccinations are not yet recognisable as a second dose in the data, they will be counted as in the category of the first dose. This applies to all second doses administered by the GGD if the first vaccination was administered by a vaccinator other than the GGD.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 561,728 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
27 July 2021 | 16:20 PM
Vaccination figures: 19 to 25 July 2021
By Sunday 25 July, it is estimated that more than 20.1 million vaccinations had been administered in the Netherlands. More than 12.2 million of those were first vaccinations, and nearly 8 million were second vaccinations. In the age group of 30-39 years, more than 1.4 million people have now received their first vaccination. More than 80% of all people over 50 have been fully vaccinated, rising to 88% of all people aged 80-89 years.
Turnout among young people aged 12-17 years continues to rise
The 27th RIVM vaccination update shows that vaccination turnout in the age group of 12-17 years has continued to increase. By week 29, 482,186 young people (41%) in this group had received their first vaccination from the Municipal Public Health Services (GGDs).
Geographic distribution
Looking at the Netherlands, vaccination turnout has been higher among various age groups in the east and south of the country, with the exception of the province of Zeeland, than in other parts of the country. This trend has been observed both among people over 65 who are now fully vaccinated, and among people aged 45-64 years. The same trend seems to be emerging cautiously among people aged 25-44 years.
This is not entirely new information. National figures for vaccination turnout in the context of the National Immunisation Programme show a similar geographic distribution. In that context as well, vaccination turnout is higher in the east and southeast of the country, and lower in municipalities in the Dutch ‘Bible belt’ and in a few bigger cities.
Vaccination coverage still rising
Vaccination coverage among people aged 70 years and older is increasing very slowly at this point; most people in these age groups have already been fully vaccinated. 90% of people aged 70-79 years are now fully vaccinated. In the younger age groups, vaccination coverage is still increasing every week. In the past week, vaccination coverage increased to 65% among people aged 45-49 years and 56% among people aged 40-44 years.
Vaccination figures: 6 January – 25 July 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 29 (2021), by type of vaccinator.
Vaccinator | Target group | Start date2 | First dose3 | Second dose | Totaal |
---|---|---|---|---|---|
GGD | People aged 90 and up | 26 January 2021 | 68, 451 | 65,844 | 134,295 |
GGD | 85-89 years | 29 January 2021 | 189,615 | 184,643 | 374,258 |
GGD | 80-84 years | 5 February 2021 | 377,492 | 368,607 | 746,099 |
GGD | 75-79 years | 6 March 2021 | 574,353 | 557,760 | 1,132,113 |
GGD | 70-74 years | 6 April 2021 | 862,491 | 826,466 | 1,688,957 |
GGD | 65-69 years | 19 April 2021 | 803,526 | 755,797 | 1,559,323 |
GGD | 60-64 years | 148,498 | 76,851 | 225,349 | |
GGD | 55-59 years | 27 April 2021 | 1,026,103 | 916,302 | 1,942,405 |
GGD | 50-54 years | 20 May 2021 | 1,021,180 | 668,444 | 1,689,624 |
GGD | 45-49 years | 26 May 2021 | 865,719 | 673,519 | 1,539,238 |
GGD | 40-44 years | 29 May 2021 | 742,590 | 466,714 | 1,209,304 |
GGD | 35-39 years | 1 June 2021 | 690,917 | 307,481 | 998,398 |
GGD | 30-34 years | 7 June 2021 | 664,068 | 158,740 | 822.808 |
GGD | 25-29 years | 11 June 2021 | 634,295 | 123,181 | 757,476 |
GGD | 18-24 years | 15 June 2021 | 903,180 | 163,743 | 1,066,923 |
GGD | 12-17 years | 22 June 2021 | 482,186 | 15,574 | 497,760 |
GGD | Age unknown | 22.650 | 1.292 | 23.942 | |
GPs (estimated)4,5 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | |
Other vaccinators (estimated)4,6 | 6 January 2021 | 925,625 | 477,990 | 1,403,615 | |
Total7 | 12,231,566 | 7,897,865 | 20,129,431 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 29, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinate people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/SPX via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- From 16 July 2021 on, people who have been vaccinated with VAX as a first dose will have the opportunity to be vaccinated with COM by the GGD for their second dose. This mainly involves people aged 60-64 years. As long as these vaccinations are not yet recognisable as a second dose in the data, they will be counted as in the category of the first dose. This applies to all second doses administered by the GGD if the first vaccination was administered by a vaccinator other than the GGD.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. In these figures, it is assumed that no more vaccines will be administered by GPs after 7 July 2021, although some GPs may still be vaccinating patients in actual practice.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,682 estimated vaccinations administered by other vaccinators, and 554,260 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
20 July 2021 | 16:35 PM
Vaccination figures: 6 January – 18 July 2021
Read the news: Vaccination turnout for people aged 25-44: 66% vaccinated at least once
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 28 (2021), by type of vaccinator.
Vaccinator | Target group | Start date2 | First dose3 | Second dose | Totaal |
---|---|---|---|---|---|
GGD | People aged 90 and up | 26 January 2021 | 68,094 | 65,458 | 133,552 |
GGD | 85-89 years | 29 January 2021 | 188,727 | 183,719 | 372.446 |
GGD | 80-84 years | 5 February 2021 | 375,784 | 366,866 | 742,650 |
GGD | 75-79 years | 6 March 2021 | 571,210 | 554,740 | 1,125,950 |
GGD | 70-74 years | 6 April 2021 | 855,872 | 820,341 | 1,676,213 |
GGD | 65-69 years | 19 April 2021 | 794,377 | 746,750 | 1,541,127 |
GGD | 60-64 years | 136,930 | 65,793 | 202,723 | |
GGD | 55-59 years | 27 April 2021 | 1,005,134 | 881,468 | 1,886,602 |
GGD | 50-54 years | 20 May 2021 | 996,038 | 567,120 | 1,563,158 |
GGD | 45-49 years | 26 May 2021 | 836,359 | 497,470 | 1,333,829 |
GGD | 40-44 years | 29 May 2021 | 727,570 | 297,942 | 1,025,512 |
GGD | 35-39 years | 1 June 2021 | 678,308 | 178.141 | 856,449 |
GGD | 30-34 years | 7 June 2021 | 652,329 | 113,775 | 766,104 |
GGD | 25-29 years | 11 June 2021 | 622,659 | 100,144 | 722,803 |
GGD | 18-24 years | 15 June 2021 | 880,580 | 144,955 | 1,025,535 |
GGD | 12-17 years | 22 June 2021 | 376,238 | 13,114 | 389,352 |
GGD | Age unknown | 10,868 | 892 | 11,760 | |
GPs (estimated)4,5 | 15 February 2021 | 1,228,627 | 1,088,917 | 2,317,544 | |
Other vaccinators (estimated)4,6 | 6 January 2021 | 925,607 | 476,251 | 1,401,858 | |
Total7 | 11,931,311 | 7,163,856 | 19,095,167 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine 1, weeks 1 through 28, 2021, by type of vaccinator.
COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/SPX via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- From 16 July 2021 on, people who have been vaccinated with VAX as a first dose will have the opportunity to be vaccinated with COM by the GGD for their second dose. As long as these vaccinations are not yet recognisable as a second dose in the data, they will be counted as a first dose, which is the case if the first vaccination was administered by a vaccinator other than the GGD.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. It is assumed that no more vaccines will be administered by GPs after 7 July 2021.
- For the distribution of first and second doses, the same assumption is used for VAX as for vaccinations by GPs (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,664 estimated vaccinations administered by other vaccinators, and 546,414 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ category, since 1 dose of this vaccine is sufficient.
13 July 2021 | 17:00 PM
Vaccination figures: 6 January – 11 July 2021
Read the news: Vaccination coverage is rising, while data is increasingly comprehensive
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 27 (2021), by type of vaccinator.
Vaccinator | Target group | Start date2 | First dose | Second dose | Total |
---|---|---|---|---|---|
GGD |
|
26 January 2021 | 68,041 | 64,539 | 132,580 |
GGD |
|
29 January 2021 | 188,628 | 181,265 | 369,893 |
GGD |
|
05 February 2021 | 375,620 | 362,206 | 737,826 |
GGD |
|
06 March 2021 | 570,864 | 546,431 | 1,117,295 |
GGD |
|
06 April 2021 | 855,265 | 802,284 | 1,657,549 |
GGD |
|
19 April 2021 | 792,928 | 722,239 | 1,515,167 |
GGD |
|
126,414 | 60,175 | 186,589 | |
GGD |
|
27 April 2021 | 1,002,245 | 754,446 | 1,756,691 |
GGD |
|
20 May 2021 | 991,443 | 367,37 | 1,358,822 |
GGD |
|
26 May 2021 | 830,760 | 249,527 | 1,080,287 |
GGD |
|
29 May 2021 | 721,140 | 145,385 | 866,525 |
GGD |
|
01 June 2021 | 668,766 | 105,590 | 774,356 |
GGD |
|
07 June 2021 | 637,822 | 90,119 | 727,941 |
GGD |
|
11 June 2021 | 603,987 | 84,801 | 688,788 |
GGD |
|
18 June 2021 | 844,123 | 126,239 | 970,362 |
GGD |
|
22 June 2021 | 256,779 | 10.260 | 267,039 |
GGD |
Age unknown |
4,717 | 579 | 43,4343 | |
GPs (estimated)4,5 | 15 February 2021 | 1,228,627 | 1,089,034 | 2,317,670 | |
Other vaccinators (estimated)4,6 | 06 January 2021 | 925,580 | 465,738 | 1,391,318 | |
Total7 | 11,693,749 | 6,228,245 | 17,960,1323 |
Footnotes:
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine, weeks 1 through 27, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); SPX = Spikevax® (Moderna®); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- Due to incomplete transmission of vaccination data by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in weeks 23-25 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned. In total, this involves an estimated 38,138 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for SPX, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses. As of 07 July 2021, it is assumed that the estimated number of vaccinations by general practitioners will not increase, even though vaccines may still be administered in the practice.
- For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For SPX, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,637 estimated vaccinations administered by other vaccinators, and 532,289 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient
06 July 2021 | 17:00 PM
Vaccination figures: 28 June – 4 July 2021
By Sunday 4 July, it is estimated that more than 16.7 million vaccinations had been administered in the Netherlands. More than 10.8 million of those were first vaccinations, and over 5.8 million were second vaccinations. The daily number of vaccinations administered is posted on the Coronavirus Dashboard.
First vaccination
Among people over 65, turnout for a first vaccination is high: 92%. Turnout for a first vaccination is rising steadily among the under-60 age groups. People aged 50-54 and 55-59 years have reached a turnout of 81% and 85% so far, while people aged 40-44 and 45-59 years are at 72% and 76%. Vaccination turnout is at 55% and 64% for people aged 30-34 and 35-39 years, and people aged 20-24 and 25-29 years have now reached 38% and 47%. The age group of 17-19 years has reached 29% for a first vaccination. The youngest age group of 12-16 years has been included in this report for the first time; they have been able to make an appointment since last Friday. Young people aged 12-17 years with a medical indication were able to make an appointment earlier. Vaccination turnout for the age group of 12-16 years is now at 2%.
Vaccination turnout by municipality
The figure shows turnout by municipality among people over 65 years old and people between 45 and 64 who have received at least one vaccination. In almost all municipalities, turnout among over-65s is at least 85%. Turnout for people between 45 and 64 years old is above 75% in most municipalities and above 85% in many municipalities. These age groups have continued to show rising vaccination figures over the past few weeks.
Vaccination coverage is increasing
Vaccination coverage indicates what percentage of the population has been fully vaccinated. This applies to people who have received two vaccinations, or one vaccination with the Janssen vaccine. People who have received one vaccination after previously having had COVID-19 are not yet counted as fully vaccinated in this update, because the data is not yet complete.
72% of all adults living in the Netherlands have now received at least their first vaccination, and at least 41% are fully vaccinated. This data is based on registered vaccinations in the national vaccination system.
Vaccination coverage among people over 65 has reached 84%. More and more people between 50 and 60 years old are fully vaccinated: 57% of people aged 55-59 and 41% of people aged 50-54. In the next few weeks, vaccination coverage will continue to rise.
Vaccination coverage among people aged 50-54 rose more quickly in the first few weeks after this age group was eligible, compared to recent weeks. This can be explained by the fact that some of the people in this age group (born in 1967 and 1968) were given the Janssen vaccine. These people count as fully vaccinated after one vaccination. People from other birth years within this age group still need a second vaccination before they are fully vaccinated.
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 26 (2021), by type of vaccinator.
Uitvoerder | Doelgroep | Startdatum2 | Eerste dosis | Tweede dosis | Totaal4 |
---|---|---|---|---|---|
GGD |
|
26 January 2021 | 67,918 | 64,457 | 132,375 |
GGD |
|
29 January 2021 | 188,380 | 181,043 | 369,423 |
GGD |
|
05 February 2021 | 375,086 | 361,632 | 736,718 |
GGD |
|
06 March 2021 | 569,649 | 545,525 | 1,115,174 |
GGD |
|
06 April 2021 | 853,013 | 800,241 | 1,653,254 |
GGD |
|
19 April 2021 | 789,732 | 718,385 | 1,508,117 |
GGD |
|
116,856 | 58,909 | 175,765 | |
GGD |
|
27 April 2021 | 993,945 | 653,597 | 1,647,542 |
GGD |
|
20 May 2021 | 976,784 | 263,947 | 1,240,731 |
GGD |
|
26 May 2021 | 810,607 | 165,209 | 975,816 |
GGD |
|
29 May 2021 | 695,802 | 115,087 | 810,889 |
GGD |
|
01 June 2021 | 628,691 | 91,265 | 719,956 |
GGD |
|
07 June 2021 | 572,562 | 80,934 | 653,496 |
GGD |
|
11 June 2021 | 490,166 | 76,324 | 566,490 |
GGD |
|
15 June 2021 | 383,883 | 82,543 | 466,426 |
GGD |
|
18 June 2021 | 172,834 | 39,390 | 212,224 |
GGD |
|
22 June 2021 | 18,985 | 455 | 19,440 |
GGD |
Age unknows |
1,756 | 376 | 40,2703 | |
GPs (estimated)4,5 | 15 February 2021 | 1,228,643 | 1,068,688 | 2,297,331 | |
Other vaccinators (estimated)4,6 | 06 January 2021 | 925,580 | 459,707 | 1,385,287 | |
Total7 | 10,860,872 | 5,827,714 | 16,726,7243 |
Table 1: Number of people who received a first and possibly also second dose of COVID-19 vaccine, weeks 1 through 26, 2021, by type of vaccinator.
- COM = Comirnaty® (Pfizer/BioNTech); MOD = Spikevax® (formerly COVID-19 Vaccine Moderna®); VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- Due to incomplete transmission of vaccination data by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in week 23-25 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned. In total, this involves an estimated 38,138 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
- For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 206,637 estimated vaccinations administered by other vaccinators, and 462,641 vaccinations administered by the GGD, involved JANSS. These vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient
22 June 2021 | 16:00 PM
Vaccination figures: 14 to 20 June 2021
By Sunday 20 June, it is estimated that nearly 13.9 million vaccinations had been administered in the Netherlands. More than 8.6 million of those were first vaccinations, and 4.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Vaccination turnout is high
Vaccination turnout among all age groups is high or has increased significantly. Turnout has been high in the age groups over 65: between 84% and 92% for the first vaccination.
People aged 55-59 years have reached a turnout of 81% so far, while people aged 50-54 years are at 71% for the first vaccination. Turnout for people aged 45-49 and 40-44 has risen to 60% and 48% respectively.
The age groups that were invited most recently are showing an increase in turnout: the 35-39 age group is at 27%, the 30-34 age group is at 16%, and turnout among people aged 25-29 years is at 14%.
Vaccination turnout by municipality
The figure shows turnout by municipality among people over 65 years old who have received at least one vaccination. Regional differences in turnout are minimal. Most municipalities have seen a turnout of at least 85%. A figure showing turnout among people under 65 is expected to be published next week.
Vaccination coverage is increasing
Vaccination coverage indicates what percentage of the population has been fully vaccinated. This applies to people who have received two vaccinations with Pfizer, Moderna or AstraZeneca, or one vaccination with Janssen. People who have received one vaccination after previously having had COVID-19 are also fully vaccinated. This final group is still counted among the group that has received one vaccination. In the data supplied to RIVM, it is not yet possible to separate the number of people who have received one vaccination after having had COVID-19 from other people who have received one vaccination.
Vaccination coverage among people over 65 has increased and now ranges from over 65% to nearly 87%. Many age groups under 65 years old will be receiving their second vaccination in the next few weeks. Vaccination coverage will continue to increase as the vaccination programme progresses.
Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). RIVM has not yet received all the data. As a result, the vaccination records are not yet complete and the actual turnout is somewhat higher.
Technical malfunction at the GGD
Due to a technical malfunction at the GGD GHOR, a number of vaccinations on a number of days over the past two weeks were not fully reported to RIVM. Therefore, an estimate was provided based on the number of appointments scheduled on those days. This involves approximately 840,000 vaccinations. With this estimate, it is not possible to make a distinction according to age or first and second dose. For that reason, the 840,000 vaccinations have only been counted in the total number of vaccinations. The GGD is working to resolve the technical malfunction.
Vaccination figures 6 January to 13 June 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 24 (2021), by type of vaccinator.
Vaccinator | Target group | Start date2 | First dose | Second dose | Total |
---|---|---|---|---|---|
GGD |
|
26 January 2021 | 67,414 | 63,874 | 131,288 |
GGD |
|
29 January 2021 | 187,792 | 179,358 | 367,150 |
GGD |
|
05 February 2021 | 373,753 | 357,555 | 731,308 |
GGD |
|
06 March 2021 | 566,477 | 539,413 | 1,105,890 |
GGD |
|
06 April 2021 | 848,286 | 779,227 | 1,627,513 |
GGD |
|
19 April 2021 | 782,299 | 620,747 | 1,403,046 |
GGD |
|
74,529 | 54,100 | 128,629 | |
GGD |
|
27 April 2021 | 952,394 | 231,470 | 1,183,864 |
GGD |
|
20 May 2021 | 860,990 | 84,534 | 945,524 |
GGD |
|
26 May 2021 | 628,273 | 60,997 | 689,270 |
GGD |
|
29 May 2021 | 459,110 | 46,085 | 505,195 |
GGD |
|
1 June 2021 | 248,200 | 38,342 | 286,542 |
GGD |
|
7 June 2021 | 140,047 | 35,655 | 175,702 |
GGD |
|
11 June 2021 | 118,114 | 34,497 | 152,611 |
GGD |
|
15 June 2021 | 118,301 | 40,858 | 159,159 |
GGD |
|
18 June 2021 | 59,841 | 17,395 | 77,236 |
GGD |
|
1,194 | 339 | 841,9443 | |
Vaccinated by GPs (estimated)4,5 | 15 February 2021 | 1,228,660 | 755,904 | 1,984,564 | |
Vaccinated by other vaccinators (estimated)4,6 | 06 January 2021 | 906,753 | 471,976 | 1,378,729 | |
Total7 | 8,622,427 | 4,412,326 | 13,875,1643 |
Voetnoten:
- COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Service (GGD) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- Due to incomplete transmission of vaccination data by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in weeks 23-24 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned. In total, this involves an estimated 840,411 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered by GPs within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
- For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 190,762 estimated vaccinations administered by other vaccinators, and 259,183 vaccinations administered by the GGD, involved JANSS. This vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient.
15 June 2021 | 16:15 PM
Vaccination figures: 7 to 13 June 2021
By Sunday 13 June, it is estimated that more than 12.4 million vaccinations had been administered in the Netherlands. Almost 8.3 million of those were first vaccinations, and 4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Vaccination turnout is high
Vaccination turnout among all age groups is high or has increased significantly. Turnout has been high in the age groups over 65: between 83% and 92% for the first vaccination. People aged 55-59 years have reached a turnout of 80% so far, while people aged 50-54 years are at 68% for the first vaccination. Vaccination turnout for people aged 45-49 and 40-44 has risen to 51% and 41% respectively, and people aged 35-39 years are at 22%. The age groups of 30-34 years and 25-29 years have been added, and have reached a turnout of 14% and 13% for the first vaccination.
Vaccination turnout by municipality
The figure shows turnout by municipality among people over 65 years old who have received at least one vaccination. Regional differences in turnout are minimal. Most municipalities have seen a turnout of at least 85%.
Vaccination coverage is increasing
Vaccination coverage indicates what percentage of the population has been fully vaccinated. This applies to people who have received one vaccination with the Janssen vaccine or two vaccinations with another COVID-19 vaccine. Data is not yet available on people who have received one vaccination after previously having had COVID-19.
Vaccination coverage among people over 65 is now between 58% and 86%. A number of the over-65 age groups where vaccination coverage is not very high yet are still scheduled to receive a second vaccination. The same applies to most people under 60. Vaccination coverage will continue to increase as the vaccination programme progresses.
Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). RIVM National Institute for Public Health and the Environment has not yet received all the data. As a result, the vaccination records are not yet complete and the actual turnout is somewhat higher.
Technical malfunction at the GGD
Due to a technical malfunction at GGD GHOR, a number of vaccinations on a number of days were not fully reported to RIVM. All the vaccinations that were administered have been registered by the Municipal Public Health Services (GGDs). An estimate was made based on the number of appointments scheduled on those days. This involves approximately 137,000 vaccinations. Based on this estimate, it was not possible to make a distinction according to age or first and second dose. For that reason, the 137,000 vaccinations have only been counted in the total number of vaccinations. GGD GHOR is working to resolve the technical malfunction. These vaccinations are expected to be fully processed and incorporated into the next weekly update.
Vaccination figures 6 January to 13 June 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine1, week 1 to week 23 (2021), by type of vaccinator.
Vaccinator | Target group | Start date2 | First dose | Second dose | Total |
---|---|---|---|---|---|
GGD |
|
26 January 2021 | 67,371 | 63,682 | 131,053 |
GGD |
|
29 January 2021 | 187,692 | 178,686 | 366,378 |
GGD |
|
05 February 2021 | 373,525 | 356,208 | 729,733 |
GGD |
|
06 March 2021 | 566,025 | 537,346 | 1,103,371 |
GGD |
|
06 April 2021 | 847,571 | 770,343 | 1,617,914 |
GGD |
|
19 April 2021 | 780,571 | 556,888 | 1,337,787 |
GGD |
|
71,075 | 52.308 | 123,383 | |
GGD |
|
27 April 2021 | 942,324 | 151,859 | 1,094,183 |
GGD |
|
20 May 2021 | 816,512 | 70,902 | 887,414 |
GGD |
|
26 May 2021 | 537,788 | 51,596 | 589,384 |
GGD |
|
29 May 2021 | 381,997 | 39,259 | 421,256 |
GGD |
|
1 June 2021 | 193,934 | 32,820 | 226,754 |
GGD |
|
7 June 2021 | 122,654 | 30,814 | 153,468 |
GGD |
|
11 June 2021 | 109,098 | 30,145 | 139,243 |
GGD |
|
114,731 | 36,327 | 151,058 | |
GGD |
|
58,260 | 15,251 | 73,511 | |
GGD |
|
1,134 | 312 | 138,5333 | |
Vaccinated by GPs (estimated)4,5 | 15 February 2021 | 1,228,637 | 610,185 | 1,838,822 | |
Vaccinated by other vaccinators (estimated)4,6 | 06 January 2021 | 884,441 | 434,660 | 1,319,101 | |
Total7 | 8,285,668 | 4,019,591 | 12,442,3463 |
- COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
- The Municipal Public Health Service (GGD) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June 2021 on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- Due to a technical malfunction in the vaccination data registration by GGD GHOR in CoronIT, some of the vaccinations administered by the GGD in week 23 of 2021 have been estimated based on the number of registered vaccination appointments, taking into account an average number of appointments that did not take place as planned. In total, this involves an estimated 137,087 vaccinations that have temporarily been registered as ‘age unknown’, with no distinction made between the first and second dose. For that reason, these vaccinations are only displayed in the ‘Total’ column, not in under ‘First dose’ and ‘Second dose’.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). From week 23 on, it is assumed that VAX is administered by GPs within 4 weeks. RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
- For VAX, the same assumption is used as for vaccinations by general practitioners (see above). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
- 172,542 estimated vaccinations administered by other vaccinators, and 258,536 vaccinations administered by the GGD, involved JANSS. This vaccinations are only displayed in the ‘First dose’ column, since 1 dose of this vaccine is sufficient.
8 June 2021 | 16:50 PM
Vaccination figures: 31 May to 6 June 2021
By Sunday 6 June, it is estimated that more than 10.7 million vaccinations had been administered in the Netherlands. More than 7.3 million of those were first vaccinations, and 3.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Vaccination turnout by age group
More than 50% of people over the age of 18 have received a first vaccination. Vaccination turnout in people over 65 is between 83% and 93% for the first vaccination. Turnout among people under 60 is rising quickly as the campaign moves forward. Turnout for the first vaccination has now reached 71% for people aged 55-59 and 50% for people aged 50-54. Vaccination turnout for people aged 45-49 and 40-45 is now at 29% and 23%. 14% of people aged 35-39 years have now received a first vaccination.
Vaccination turnout by municipality
The figures for vaccination turnout by municipality among people over 65 years old clearly show that regional differences have grown even smaller. The number of municipalities with a turnout higher than 85% among people over 65 has continued to increase.
Data
Vaccination turnout is calculated on the basis of data from the Municipal Public Health Services (GGDs) and from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). The data from those sources registered in CIMS is not yet complete. As a result, the actual turnout is somewhat higher.
Vaccinations with the Janssen vaccine are included in the vaccination reports from GGDGHOR as of this week. A technical change in the GGDGHOR reporting process had to be implemented to make that possible. In implementing that change, it became apparent that people who received only one vaccination after a previous COVID-19 infection had only been partially included in the figures reported by GGDGHOR and RIVM. That oversight has been corrected, bringing the number of vaccinations reported by RIVM to nearly 160,000 more vaccinations than last week.
Vaccination figures 6 January to 6 June 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 22 (2021), by type of vaccinator.
Vaccinator | Target group | Start date1 | First dose | Second dose | Total |
---|---|---|---|---|---|
GGD |
|
26 January 2021 | 68,156 | 63,434 | 131,590 |
GGD |
|
29 January 2021 | 189,904 | 177,652 | 367,556 |
GGD |
|
05 February 2021 | 377,326 | 354,659 | 731,985 |
GGD |
|
06 March 2021 | 571,939 | 532,996 | 1,104,935 |
GGD |
|
06 April 2021 | 858,675 | 735,629 | 1,594,304 |
GGD |
|
19 April 2021 | 775,989 | 341,508 | 1,117,497 |
GGD |
|
65,740 | 48,069 | 113,809 | |
GGD |
|
27 April 2021 | 826,332 | 73,505 | 899,837 |
GGD |
|
20 May 2021 | 592,507 | 59.243 | 651,750 |
GGD |
|
26 May 2021 | 282,177 | 43,057 | 325,234 |
GGD |
|
29 May 2021 | 197,608 | 32,760 | 230,368 |
GGD |
|
118,021 | 27,529 | 145,550 | |
GGD |
|
101,190 | 25,826 | 127,016 | |
GGD |
|
95,323 | 25,538 | 120,861 | |
GGD |
|
102,496 | 31,115 | 133,611 | |
GGD |
|
50,631 | 13,243 | 63,874 | |
GGD |
|
976 | 263 | 1.239 | |
Vaccinated by GPs (estimated)2,3 | 15 February 2021 | 1,228,601 | 432,044 | 1,660,645 | |
Vaccinated by other vaccinators (estimated) | 06 January 2021 | 869,315 | 383,740 | 1,253,055 | |
Total | 7,372,906 | 3,401,810 | 10,774,716 |
Footnote table:
COM = Comirnaty® (Pfizer/BioNTech); MOD = COVID-19 Vaccine Moderna®; VAX = Vaxzevria® (AstraZeneca); JANSS = COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination. For all other vaccines currently in use, two doses are recommended for full vaccination, with the exception of people who were previously infected, for whom one dose is sufficient.
1 The Municipal Public Health Services (GGDs) vaccinates people living at home who are mobile enough to travel to the GGD vaccination site (in groups by age), care workers (from 6 January 2021 on), people who are eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the age group. On the Wadden Islands, vaccination started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years were initially primarily vaccinated with VAX via their GP; from 5 June on, they can also make an appointment for vaccination with COM/MOD via the GGD. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (VAX) left over after vaccinating people aged 60-64 years. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
2 A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For COM, it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if COM is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for COM, 10 doses per vaccine vial for MOD, 11 doses per vaccine vial for VAX, and 5 doses per vaccine vial for JANSS. It is assumed that VAX was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
3 Second doses of VAX will be administered from week 18 on; based on the rollout schedule for VAX and the number of inhabitants per province, the distribution of VAX administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
4 For VAX, the same assumption is used as for vaccinations by general practitioners (see footnote 3). For MOD, up to and including week 21, all second doses are assumed to have been given exactly 4 weeks after the first dose; from week 22 on, the distribution according to first and second dose is based on the distribution in CIMS. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery are assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, COM deliveries to other vaccinators are all assumed to be second vaccine doses.
5 166,141 estimated vaccinations administered by other vaccinators, and 217,994 vaccinations administered by the GGD, involved JANSS. This involves the first dose, since 1 dose of this vaccine is sufficient.
1 June 2021 | 16:50 PM
Vaccination figures: 24 to 30 May 2021
By Sunday 30 May, it is estimated that more than 9.3 million vaccinations had been administered in the Netherlands. More than 6.5 million of those were first vaccinations, and 2.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard. The actual number of doses administered is about 78,000 higher than presented in the current overview. This is due to the data registered by the Municipal Public Health Services (GGDs) regarding the Janssen vaccine, which has been rolled out for vaccination since 28 May; this data has not yet been processed.
Vaccination turnout
As of this week, turnout will no longer be calculated solely on the basis of GGD data, but will also be supplemented with data from other vaccinators, such as GPs, hospitals and care institutions. Data from other vaccinators comes from the national registration system (CIMS). The data from those sources registered in CIMS is not yet complete; this applies in particular to people aged 60-64 years who are vaccinated by their GP. As a result, the actual turnout is likely to be somewhat higher.
Vaccination turnout among people over 65 varies somewhat per age group, ranging from 82% to 92% for the first vaccination. Turnout for the first vaccination has now reached 59% for people aged 50-54 and 25% for people aged 50-54. On average, 87% of people aged 65 years and older have now had their first vaccination. RIVM published figures on vaccination turnout last Friday.
Turnout per municipality
Regional differences are minimal. Turnout in most municipalities is above 75%, and frequently higher than 85%.
Vaccination figures 6 January to 30 May 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 21 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Age groups (including healthcare workers) vaccinated by GGD2 | COM/AZ/MOD | ||||
|
26 January 2021 | 67,905 | 62,934 | 130,839 | |
|
29 January 2021 | 189,202 | 176,321 | 365,523 | |
|
05 February 2021 | 375,683 | 352,054 | 727,737 | |
|
06 March 2021 | 567,149 | 522,095 | 1,089,244 | |
|
06 April 2021 | 828,936 | 564,086 | 1,393,022 | |
|
19 April 2021 | 728,180 | 120,218 | 848,461 | |
|
63,461 | 47,051 | 110,512 | ||
|
27 April 2021 | 678,160 | 60,859 | 739,019 | |
|
20 May 2021 | 279,132 | 52,675 | 313,807 | |
|
26 May 2021 | 175,291 | 38,122 | 213,413 | |
|
29 May 2021 | 121,894 | 28,975 | 150,869 | |
|
97,225 | 24,409 | 121,634 | ||
|
86,961 | 23,038 | 109,999 | ||
|
81,829 | 23,146 | 104,975 | ||
|
87,838 | 28,663 | 116,501 | ||
|
41,950 | 12,210 | 54,160 | ||
|
868 | 202 | 1,070 | ||
Vaccinated by GPs (estimated)3,4 | 15 February 2021 | AZ | 1,228,601 | 300,383 | 1,528,984 |
Vaccinated by other vaccinators (estimated)3,5,6 | 06 January 2021 | COM/MOD/AZ/JANSS | 851,812 | 367,570 | 1,219,382 |
Total | 6,552,077 | 2,805,074 | 9,357,151 |
Footnote table:
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
- The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on), people who would normally be eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the first group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog), and from 25 May 2021 for people aged 18 years and older. People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. The vaccinations administered with the Janssen vaccine have not yet been included in these figures. This involves about 26,000 vaccinations a day. The Municipal Public Health Services (GGDs) started administering the Janssen vaccine on 28 May 2021. This means that the figures for the vaccinations administered by the GGD are underreported by about 78,000 vaccinations.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
- 156,277 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
- For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, deliveries to other vaccinators are all assumed to be second vaccine doses.
25 May 2021 | 16:15 PM
Vaccination figures: 17 to 23 May 2021
By Sunday 23 May, it is estimated that more than 8.4 million vaccinations had been administered in the Netherlands. More than 6.1 million of those were first vaccinations, and 2.3 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Vaccination coverage based on GGD data
The number of people vaccinated by the GGD is rising rapidly every week. Vaccination coverage among people aged 55-59 has risen to 42% for the first vaccination. Vaccination coverage for people aged 50-54 has been included for the first time, and has now reached 16% for the first vaccination.
Vaccination coverage among people over 65 living at home has also increased and varies somewhat per age group, ranging from 73% to 91% for the first vaccination. Coverage in these age groups continues to rise slightly every week. People aged 60-64 years are not included in these charts displaying GGD data, since that age group is primarily vaccinated by their GPs.
Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
Vaccination figures 6 January to 23 May 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 19 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Age groups (including healthcare workers) vaccinated by GGD2 | COM/AZ/MOD | ||||
|
26 January 2021 | 67,802 | 62,198 | 130,000 | |
|
29 January 2021 | 188,890 | 174,689 | 363,579 | |
|
05 February 2021 | 374,898 | 347,665 | 722,563 | |
|
06 March 2021 | 563,578 | 460,534 | 1,024,112 | |
|
06 April 2021 | 813,695 | 336,600 | 1,150,295 | |
|
19 April 2021 | 717,866 | 40,202 | 758,068 | |
|
62,067 | 42,376 | 104,443 | ||
|
27 April 2021 | 525,395 | 51,648 | 577,043 | |
|
20 May 2021 | 204,613 | 44,783 | 249,398 | |
|
140,507 | 32,300 | 172,807 | ||
|
101,353 | 24,239 | 125,592 | ||
|
81,381 | 20,383 | 101,764 | ||
|
73,234 | 19,370 | 92.604 | ||
|
69,031 | 19,610 | 88,641 | ||
|
74,600 | 24,246 | 98,846 | ||
|
34,312 | 10,444 | 44,756 | ||
|
833 | 147 | 980 | ||
Vaccinated by GPs (estimated)3,4 | 15 February 2021 | AZ | 1,228,601 | 226,737 | 1,455,338 |
Vaccinated by other vaccinators (estimated)3,5,6 | 06 January 2021 | COM/MOD/AZ/JANSS | 830,697 | 366,391 | 1,197,088 |
Total | 6,153,355 | 2,304,562 | 8,457,917 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
- The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on), people who would normally be eligible for the influenza vaccination (from 6 May 2021), and young people aged 16-18 years living at home who are in medical high-risk groups (from 18 May 2021). The start date in the table refers to the first group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19. From week 20 on, 100% of deliveries are assumed to be second vaccine doses.
- 142,069 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
- For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17 on, deliveries to other vaccinators are all assumed to be second vaccine doses.
18 May 2021 | 16:15 PM
Vaccination figures: 10 to 16 May 2021
By Sunday 16 May, it is estimated that more than 7.4 million vaccinations had been administered in the Netherlands. More than 5,6 million of those were first vaccinations, and nearly 1.8 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard
Vaccination coverage based on GGD data
As of this week, charts displaying vaccination coverage will be provided again. They show vaccination coverage per age group based on the data provided by the Municipal Public Health Services (GGDs). The number of people vaccinated by the GGD is now rising rapidly every week. Among people aged 65 years and older living at home, vaccination coverage is now over 70% for the first vaccination and is still increasing. Vaccination coverage among all people over 65 is higher than what is being reported based on GGD figures, because this group also includes people in residential institutions and people who were vaccinated by their GP. People aged 60-64 years are not included in these charts. This age group is mainly vaccinated by their GPs, and the data records on those vaccinations are not yet complete.
Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
Vaccination figures 6 January to 16 May 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 19 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Age groups (including healthcare workers) vaccinated by GGD2 | COM/AZ/MOD | ||||
|
26 January 2021 | 67,584 | 61,386 | 128,970 | |
|
29 January 2021 | 188,360 | 172,739 | 361,099 | |
|
05 February 2021 | 373,439 | 341,726 | 715,165 | |
|
06 March 2021 | 558,072 | 322,516 | 880,588 | |
|
06 April 2021 | 802,828 | 146,983 | 949,811 | |
|
19 April 2021 | 704,934 | 16,417 | 721,351 | |
|
60,773 | 40,814 | 101,587 | ||
|
27 April 2021 | 359,812 | 49,536 | 409,348 | |
|
126,847 | 42,794 | 169,641 | ||
|
90,420 | 30,659 | 121,079 | ||
|
67,020 | 22,730 | 89,750 | ||
|
55,203 | 19,036 | 74,239 | ||
|
50,781 | 18,153 | 68,934 | ||
|
48,235 | 18,256 | 66,491 | ||
|
54,660 | 22,797 | 77,457 | ||
|
23,777 | 9,912 | 33,689 | ||
|
770 | 128 | 898 | ||
Vaccinated by GPs (estimated)3,4 | 15 February 2021 | AZ | 1,228,601 | 90,322 | 1,318,923 |
Vaccinated by other vaccinators (estimated)3,5,6 | 06 January 2021 | COM/MOD/AZ/JANSS | 799,914 | 359,995 | 1,159,909 |
Total | 5,662,030 | 1,786,899 | 7,448,929 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
- 2. The Municipal Public Health Services (GGDs) vaccinates people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups), care workers (from 6 January 2021 on) and people who would normally be eligible for the influenza vaccination (from 6 May 2021). The start date in the table refers to the former group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). People aged 60-64 years will primarily be vaccinated with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are mostly care workers (from 06 January 2021), inhabitants of the Wadden Islands (from 16 February 2021), and people who would normally be eligible for the influenza vaccination. Therefore, this does not include everyone in this age group (living at home). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be vaccinated by their GP. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution of AZ vaccinations administered by GPs is assumed to be 60% first dose and 40% second dose in week 18 and 70% first dose and 30% second dose in week 19.
- 124,373 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
- For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other
11 May 2021 | 16:30 PM
Vaccination figures: 3 to 9 May 2021
By Sunday 9 May, it is estimated that more than 6.4 million vaccinations had been administered in the Netherlands. Almost 5 million of those were first vaccinations, and over 1.4 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard
Last week, GPs started administering the second vaccination, primarily to people aged 60-64 years. People over 65 who did not respond to the invitation for vaccination earlier can still make an appointment: Calling all people over 65: make a vaccination appointment now
Number of vaccinations given
This weekly update is based on the number of vaccinations registered by the Municipal Public Health Services (GGDs) and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
Vaccination figures 6 January to 9 May 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 18 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Older people living at home vaccinated by the GGD2 | |||||
|
26 January 2021 | COM | 67,112 | 60,713 | 127,825 |
|
29 January 2021 | COM | 186,785 | 170,996 | 357,781 |
|
05 February 2021 | COM | 370,079 | 336,728 | 706,807 |
|
06 March 2021 | COM | 550,946 | 230,068 | 781,014 |
|
06 April 2021 | COM | 783,223 | 49,591 | 832,814 |
|
19 April 2021 | COM | 592,880 | 13,810 | 606,690 |
|
diverse | COM/AZ | 59,357 | 36,918 | 96,275 |
|
27 April 2021 | 173,845 | 43,875 | 217,720 | |
Other people vaccinated by the GGD |
06 January 2021 | COM/AZ | 353,256 | 156,965 | 510,221 |
Vaccinated by GPs (estimated)3 | 15 February 2021 | AZ | 1,115,125 | 41,945 | 1,157,070 |
Vaccinated by other vaccinators (estimated)3,4,5 | 06 January 2021 | COM/MOD/AZ/JANSS | 738,620 | 329,659 | 1,068,279 |
Total | 4,991,228 | 1,471,268 | 6,462,496 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
- The Municipal Public Health Services (GGDs) will vaccinate people living at home who are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups) and care workers. The start date in the table refers to the former group. On the Wadden Islands, vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog). The GGD already started vaccinating care workers from 6 January on. In principle, people aged 60-64 years will be invited for vaccination with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are therefore not the entire age group who are living at home, but primarily care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021). People born in 1955, 1954 and 1953 (aged 65-67 years) may also be contacted by their GP and offered a vaccination. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- Second doses of AZ will be administered from week 18 on; based on the rollout schedule for AZ and the number of inhabitants per province, the distribution for week 18 is assumed to be 60% first dose and 40% second dose for AZ vaccinations administered by GPs.
- 95,466 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
- For AZ, the same assumption is used as for vaccinations by general practitioners (see footnote 4). For MOD, all second doses are assumed to have been given exactly 4 weeks after the first dose. For COM, up to and including week 12, deliveries to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. For COM deliveries from week 13 on, the first and second doses are allocated pro rata based on the distribution for other
04 May 2021 | 17:00 PM
Vaccination figures: 26 April to 2 May 2021
By Sunday 2 May, it is estimated that more than 5.6 million vaccinations had been administered in the Netherlands. More than 4.4 million of those were first vaccinations, and over 1.2 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Number of vaccinations given
The update for the past week shows the number of vaccinations that have been given. This report now also includes the age groups of 55-59 years and 60-64 years among the groups vaccinated by the Municipal Public Health Services (GGDs). Within the latter age group, people are usually vaccinated by their GPs, but in special situations may be vaccinated by the GGD. This could include care workers or people living on the Wadden Islands.
This weekly update is based on the number of vaccinations registered by the GGD and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
Vaccination figures 6 January to 2 May 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 17 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Older people living at home vaccinated by the GGD2 | |||||
|
26 January 2021 | COM | 66,623 | 60,006 | 126,629 |
|
29 January 2021 | COM | 184,976 | 169,095 | 354,071 |
|
05 February 2021 | COM | 367,143 | 329,635 | 696,778 |
|
06 March 2021 | COM | 542,819 | 133,453 | 676,272 |
|
06 April 2021 | COM | 744,418 | 4,738 | 749,156 |
|
19 April 2021 | COM | 360,019 | 12,404 | 372,423 |
|
diverse | COM/AZ | 58,296 | 32,415 | 90,711 |
|
27 April 2021 | 89,310 | 37,814 | 127,124 | |
Other people vaccinated by the GGD |
06 January 2021 | COM/AZ | 318,505 | 130,806 | 449,311 |
Vaccinated by GPs (estimated)3 | 15 February 2021 | AZ | 1,052,207 | 0 | 1,052,207 |
Vaccinated by other vaccinators (estimated)3,4,5 | 06 January 2021 | COM/MOD/AZ/JANSS | 664,414 | 292,747 | 957,161 |
Total | 4,448,730 | 1,203,113 | 5,651,843 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); JANSS= COVID-19 Vaccine Janssen®. One dose of the Janssen vaccine is recommended to achieve full vaccination; for all other vaccines currently in use, two doses are recommended for full vaccination.
- Vaccinations for older people are being provided not only by the Municipal Public Health Services (GGDs), but also by GP practices. This is arranged when people are not mobile enough to travel to the GGD vaccination site (which will be applicable for older age groups more often than for younger age groups). In principle, people aged 60-64 years will be invited for vaccination with the AstraZeneca vaccine via their GP. The people aged 60-64 years in this table are care workers (from 06 January 2021) and inhabitants of the Wadden Islands (from 16 February 2021) who have been vaccinated by the GGD with the AstraZeneca vaccine or Comirnaty®. People born in 1955, 1954 and 1953 (aged 65-67 years) who are living in the provinces of Groningen, Friesland, Drenthe, Overijssel, Noord-Holland and Zeeland may also be contacted by their GP and offered a vaccination. This may happen if the GP has supplies of the vaccine (AstraZeneca) left over after vaccinating people born in 1956 to 1960. This group may decide for themselves whether they accept the invitation from their GP or are vaccinated by the GGD. Finally, people living in a residential institution may sometimes also be vaccinated by the GGD. Since we cannot identify these people separately, they have been included in this category.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna®, 11 doses per vaccine vial for Vaxzevria® (AstraZeneca), and 5 doses per vaccine vial for COVID-19 Vaccine Janssen®. It is assumed that Vaxzevria® (AstraZeneca) was not administered from 15-23 March 2021 and from 3-5 April 2021. This estimate is updated frequently as more information becomes available.
- 8,883 estimated vaccinations administered by other vaccinators involved vaccinations with COVID-19 Vaccine Janssen®. In all cases, this involves the first dose, since 1 dose of this vaccine is sufficient.
- Up to and including week 12, deliveries to care institutions that involved the same product (brand name and storage conditions) that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 53,506 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). From week 17, this assumption is applied for all vaccinators except for the GGD and GPs, and is not applied for AZ. It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.
20 April 2021 | 16:00 PM (revision 28-04-2021)
Vaccination figures: 12 to 18 April 2021
By Sunday 18 April, it is estimated that more than 4.3 million vaccinations had been administered in the Netherlands. Almost 3.4 million of those were first vaccinations, and almost 1 million were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Number of vaccinations given
The update for week 15 shows the number of vaccinations that have been given. This is based on the number of vaccinations registered by the GGD and estimates based on the number of doses delivered to other implementing parties in the vaccination programme. This estimate is updated frequently as more information becomes available.
Number of vaccine doses delivered
The number of doses of COVID-19 vaccines delivered to the Netherlands will now be displayed on the Coronavirus Dashboard.
Vaccination figures 6 January to 18 April 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 15 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Older people living at home vaccinated by the GGD2 | |||||
|
26 January 2021 | COM | 65,393 | 58,372 | 123,765 |
|
29 January 2021 | COM | 181,906 | 162,770 | 344,676 |
|
05 February 2021 | COM | 360,218 | 289,845 | 650,063 |
|
06 March 2021 | COM | 474,724 | 37,456 | 512,180 |
|
06 April 2021 | COM | 355,683 | 2,423 | 358,106 |
Other people vaccinated by the GGD |
06 January 2021 | COM/AZ | 458,394 | 208,146 | 666,540 |
Vaccinated by GPs (estimated)3 | 15 February 2021 | AZ | 862,524 | 0 | 862,524 |
Vaccinated by other vaccinators (estimated)3,4 | 06 January 2021 | COM/MOD/AZ | 605.016 | 235.085 | 840,101 |
Total | 3.363.858 | 994.097 | 4,357,955 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently being used, 2 doses are recommended.
- In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
- A continuous data flow into the national registration system (CIMS: COVID-19 vaccination Information and Monitoring System) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed from week 13 on that these doses are administered within 5 days (including the day of delivery). For all other vaccines, and if Comirnaty® (BioNTech/Pfizer) is distributed at -75°C, it is assumed that the doses will be administered within 14 days (including day of delivery). RIVM takes 1% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca). In principle, these assumptions have not been changed for the period from week 1 through 12 and can be found in the report of 30 March 2021; however, the projected wastage for these first 12 weeks has been retroactively reduced from 5% to 1%. This estimate is updated frequently as more information becomes available.
- Up to and including week 12, deliveries of the Pfizer/BioNTech vaccine to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 48,057 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.
13 April 2021 | 10:30 PM (revision 28-04-2021)
Vaccination figures: 5 to 11 April 2021
The COVID-19 vaccination figures published today in the RIVM report and on the Corona Dashboard are higher than in previous weeks. The news item about the vaccination figures provides further details on this increase.
By Sunday 11 April, it is estimated that nearly 3.5 million vaccinations had been administered in the Netherlands. Almost 2.7 million of those were first vaccinations, and over 900,000 were second vaccinations. The daily number of doses administered is posted on the Coronavirus Dashboard.
Number of vaccinations given
The update for week 14 shows the number of vaccinations that have been given. This is based on the number of vaccinations administered by the GGD and estimates based on the number of doses delivered to other vaccinators.
Number of vaccine doses delivered
In week 14, the Netherlands received 487,890 doses of the Pfizer/BioNTech vaccine and 55,440 doses of the AstraZeneca vaccine.
Vaccination figures 6 January to 11 April 2021
Table COVID-19 vaccination figures in the Netherlands: Number of people who received a first and possibly also second dose of COVID-19 vaccine, week 1 to week 14 (2021), by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Older people living at home vaccinated by the GGD2 | |||||
|
26 January 2021 | COM | 64,514 | 56,751 | 121,265 |
|
29 January 2021 | COM | 179,931 | 156,123 | 336,054 |
|
05 February 2021 | COM | 354,126 | 241,389 | 595,515 |
|
06 March 2021 | COM | 339,357 | 16,927 | 356,284 |
|
06 April 2021 | COM | 158,082 | 2,007 | 160,089 |
Other people vaccinated by the GGD |
06 January 2021 | COM/AZ | 428,410 | 205,150 | 633,560 |
Vaccinated by GPs (estimated)3 | 15-02-2021 | AZ | 583,254 | 0 | 583,254 |
Vaccinated by other vaccinators (estimated)3,4 | 06-01-2021 | COM/MOD/AZ | 553.078 | 225.164 | 778,242 |
Total | 2.660.752 | 903.511 | 3,564,263 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently available, 2 doses are recommended.
- In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
- A continuous data flow into the national registration system (CIMS) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). It is assumed that deliveries of deep-frozen Comirnaty® are used within ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that Vaxzevria® (AstraZeneca) is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). For deliveries of Vaxzevria® (AstraZeneca) or COVID-19 Vaccine Moderna® to institutions or hospitals, it is assumed that the vaccines are administered over the course of ten working days. RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca).
- Up to and including week 12, deliveries of the Pfizer/BioNTech vaccine to care institutions that took place more than 3 weeks after the first delivery were assumed to involve second vaccine doses. When it is not possible to determine whether it involved first or second doses (which is the case for 36,033 vaccinations), then the first and second doses are allocated pro rata based on the distribution for other vaccinators as reported in the update on 30 March 2021 (i.e. 64% first dose, 36% second dose). It is assumed that all second doses of Moderna were administered exactly 4 weeks after the first doses.
09 April 2021 | 18:15 PM
Weekly update on COVID-19 vaccination: 29 March to 4 April 2021
By Sunday 4 April, it is estimated that more than 2.8 million vaccinations had been administered in the Netherlands. In week 13, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine, 145,200 doses of the Moderna vaccine and 430,320 doses of the AstraZeneca vaccine.
The update for week 13, like previous weekly updates, provides estimates of the total number of vaccinations administered based on the number of vaccines delivered. However, it is no longer possible for all vaccinators to distinguish between the total number of first and second doses. This is because the same target groups can now receive both their first vaccination and second vaccination. It is also no longer possible to calculate vaccination coverage for elderly people living at home, since vaccinations for this group are now being provided not only by the Municipal Public Health Services (GGDs), but also by GP practices. RIVM is currently only receiving complete information on the number of vaccinations administered to people who were vaccinated by the GGD.
A daily estimate of the number of vaccinations that have been administered is available on the Coronavirus Dashboard provided by the Dutch national government.
Vaccination figures 6 January to 4 April 2021
Table: Number of people who received a first and possibly also second dose of COVID-19 vaccine, 1 January to 4 April 2021, by type of vaccinator.
Target group | Start date | Vaccine1 | First dose | Second dose | Total4 |
---|---|---|---|---|---|
Thuiswonende ouderen gevaccineerd door de GGD2 | |||||
|
26 January 2021 | COM | 63.731 | 54.566 | 118.297 |
|
29 January 2021 | COM | 177.945 | 145.706 | 323.651 |
|
05 February 2021 | COM | 346.431 | 157.544 | 503.975 |
|
06 March 2021 | COM | 242.759 | 7.303 | 250.062 |
|
06 April 2021 | COM | 54.790 | 1.670 | 56.460 |
Other people vaccinated by the GGD |
06 January 2021 | COM/AZ | 423.573 | 202.057 | 625.630 |
Vaccinated by GPs (estimated)3 | 15-02-2021 | AZ | 331.774 | 0 | 331.774 |
Vaccinated by other vaccinators)3,4 | 06-01-2021 | COM/MOD/AZ | 416.559 | 237.578 | 654.137 |
Totaal | 2.057.562 | 806.424 | 2.863.986 |
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= Vaxzevria® (AstraZeneca); for all the vaccines currently available, 2 doses are recommended.
- In some cases, people aged 70 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD); and people born in 1947 and 1948 were able to make an appointment slightly sooner than when they received an invitation.
- A continuous data flow into the national registration system (CIMS) is not yet available for the number of people vaccinated by other vaccinating organisations (hospitals and institutions) and by GPs. Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these vaccinators. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). It is assumed that deliveries of deep-frozen Comirnaty® are used within ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that Vaxzevria® (AstraZeneca) is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). For deliveries of Vaxzevria® (AstraZeneca) or COVID-19 Vaccine Moderna® to institutions or hospitals, it is assumed that the vaccines are administered over the course of ten working days. RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for Vaxzevria® (AstraZeneca).
- From week 13 onwards, no distinction can currently be made between first and second doses for vaccinations carried out by other vaccinators, and the first and second doses are allocated pro rata based on the distribution up to and including week 12 for other vaccinators (i.e. 64% first dose, 36% second dose). That distinction can be made again once the national registration system (CIMS) can be used to generate reports.
30 March 2021 | 16:00 PM
Weekly update on COVID-19 vaccination: 21 to 28 March 2021
By Sunday 28 March, it is estimated that nearly 1.7 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 700,000 people had received their second vaccination.
Vaccination coverage
The preliminary COVID-19 vaccination coverage for people over 90 living at home has reached 68% for the first vaccination and 55% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 79% for the first vaccination and 57% for the second. For people aged 80-84 living at home, vaccination coverage is at 82% for the first vaccination and 24% for the second. Vaccination coverage for the first COVID-19 jab has risen to 23% of people aged 75-79 living at home.
Vaccination coverage is no longer increasing as rapidly in the over-80 age groups. People in these age groups can still schedule a vaccination appointment with the Municipal Public Health Service (GGD), by calling the national appointment scheduling centre; the phone number is provided in the invitation letter.
Starting next week, eligible people who are not mobile enough to come to a vaccination site will be vaccinated at home. The GP will vaccinate them using the AstraZeneca vaccine. The vaccines will be delivered in phases per province. The GPs in Drenthe will receive extra vaccines for this group at the end of this week. Next week, deliveries will be made to GPs in North Holland, Overijssel, Groningen and Friesland. Other provinces will then start vaccinating eligible people living at home who are unable to travel, once enough vaccines have been delivered to supply those doses as well.
Vaccine deliveries
In the past week, the Netherlands received 326,430 doses of the Pfizer/BioNTech vaccine and 44,880 doses of the AstraZeneca vaccine.
Reporting
RIVM will soon start posting updates on the vaccination figures from the COVID-19 vaccination Information and Monitoring System (CIMS).
Vaccination figures 6 January to 28 March 2021
Target group | Start date | Vaccine | First dose | Second dose |
---|---|---|---|---|
Care workers providing direct COVID-19 care |
06-01-2021 | COM | 40,000 | 40,000 |
GPs |
22-01-2021 | MOD | 14,300 | 14,050 |
Other care workers & older people living at home <75 years | 06-01-2021 | COM/AZ | 400,946 | 201,123 |
Living at home | ||||
90 years and up living at home | 26-01-2021 | COM | 62,986 | 50,953 |
85-89 years | 29-01-2021 | COM | 175,827 | 127,491 |
80-84 years | 05-02-2021 | COM | 338,640 | 97,129 |
75-79 years | 06-03-2021 | COM | 144,754 | 4,400 |
60-64 years and/or high risk of severe COVID-19 (estimated) | 15-02-2021 | AZ | 198,945 | 0 |
Long-term residential care institutions (estimated) | ||||
|
18-01-2021 | COM/MOD/AZ | 199,827 | 149,497 |
|
25-01-2021 | MOD/COM | 112,265 | 5,419 |
Total | 1,688,490 |
690,062 |
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- Direct COVID-19 care and GPs: rounded figures.
- Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
- In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
- A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
- As a precautionary measure as advised by the Dutch Medicines Evaluation Board (CBG-MEB), vaccination with the AstraZeneca vaccine was temporarily on hold in week 11.
23 March 2021 | 16:15 PM
Weekly update on COVID-19 vaccination: 14 to 21 March 2021
By Sunday 21 March, it is estimated that nearly 1.5 million people in the Netherlands had received at least one COVID-19 vaccination, and more than 600,000 people had received their second vaccination. The 2 millionth vaccination was administered last week, on 19 March.
Vaccination with the AstraZeneca vaccine was temporarily on hold, which affected last week’s vaccination figures. As a result of the temporary hold, people aged 60-64, people with Down’s syndrome, people with morbid obesity, and patients and employees in mental healthcare institutions and in long-term care were not vaccinated with the AstraZeneca vaccine last week. Vaccination with the AstraZeneca vaccine started again this week.
Vaccination coverage
The preliminary COVID-19 vaccination coverage for people over 90 living at home has reached 67% for the first vaccination and 48% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 78% for the first vaccination and 45% for the second vaccination. Vaccination coverage among people aged 80-84 living at home has risen to 80% for the first vaccination and 13% for the second vaccination. Vaccination coverage for the first COVID-19 jab has risen to 15% of people aged 75-79 living at home.
Most people in the over-80 age groups have received their vaccination(s). Vaccination coverage in these age groups is increasing less rapidly than in the first weeks after vaccination started. There are people in these age groups who have not yet been vaccinated. It is important for people in these age groups who want to be vaccinated to schedule an appointment as soon as possible. Everyone in these older age groups can now schedule a vaccination appointment with the Municipal Public Health Service (GGD). They can make an appointment by calling the national appointment scheduling centre; the phone number is provided in the invitation letter. In the very near future, GPs will start providing vaccinations for elderly people living at home who are not mobile enough to come to the GGD.
Vaccine deliveries
In the past week, the Netherlands received 218,790 doses of the Pfizer/BioNTech vaccine, 44,880 doses of the AstraZeneca vaccine, and 96,000 doses of the Moderna vaccine.
Reporting
RIVM will soon start reporting on the vaccination figures from the COVID-19 vaccination Information and Monitoring System (CIMS). Based on the data in CIMS, it will be possible to show vaccination coverage by age group, region, municipality and gender. It will still be possible to display a breakdown of vaccination figures based on which vaccine brand was administered and which type of implementing party administered it. The breakdown by target group (care workers, general practitioners, institutional residents and people at high risk for severe COVID-19) will no longer be provided.
Vaccination figures 6 January to 21 March 2021
Target group | Start date | Vaccine | First dose | Second dose |
---|---|---|---|---|
Care workers providing direct COVID-19 care |
06-01-2021 | COM | 40,000 | 40,000 |
GPs |
22-01-2021 | MOD | 14,300 | 14,050 |
Other care workers & older people living at home <75 years | 06-01-2021 | COM/AZ | 360,417 | 198,194 |
Living at home | ||||
90 years and up living at home | 26-01-2021 | COM | 62,328 | 44,874 |
85-89 years | 29-01-2021 | COM | 173,620 | 99,124 |
80-84 years | 05-02-2021 | COM | 328,646 | 51,984 |
75-79 years | 06-03-2021 | COM | 94,649 | 2,349 |
60-64 years and/or high risk of severe COVID-19 (estimated) | 15-02-2021 | AZ | 154,803 | 0 |
Long-term residential care institutions (estimated) | ||||
|
18-01-2021 | COM/MOD/AZ | 171,929 | 149,497 |
|
25-01-2021 | MOD/COM | 91,797 | 5,419 |
Total | 1,492,489 |
605,491 |
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- Direct COVID-19 care and GPs: rounded figures.
- Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
- In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
- A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
- As a precautionary measure as advised by the Dutch Medicines Evaluation Board (CBG-MEB), vaccination with the AstraZeneca vaccine was temporarily on hold in week 11.
16 March 2021 | 16:10 PM
Weekly update on COVID-19 vaccination: 8 to 14 March 2021
By Sunday 14 March, it is estimated that nearly 1.4 million people in the Netherlands had received at least one COVID-19 vaccination, and nearly 500,000 people had received their second vaccination.
Vaccination coverage
The preliminary COVID-19 vaccination coverage for people over 90 living at home has risen to 66% for the first vaccination and 37% for the second vaccination. Among people aged 85-89 living at home, vaccination coverage has reached 76% for the first vaccination and more than 21% for the second vaccination. Vaccination coverage for the first COVID-19 jab has reached 74% of people aged 80-84 living at home, and 7% of people aged 75-79 living at home.
People from these age groups can still schedule a vaccination appointment with the Municipal Public Health Service (GGD). Vaccination will also start shortly for non-mobile elderly people living at home who cannot come to the GGD for an appointment.
Vaccine deliveries
In the past week, the Netherlands received 218,790 doses of the Pfizer/BioNTech vaccine and 95,040 doses of the AstraZeneca vaccine. There were no vaccine deliveries from Moderna in the past week.
Vaccination figures 6 January to 14 March 2021
Target group | Start date | Vaccine | First dose | Second dose |
---|---|---|---|---|
Care workers providing direct COVID-19 care |
06-01-2021 | COM | 40,000 | 40,000 |
GPs |
22-01-2021 | MOD | 14,300 | 13,300 |
Other care workers & older people living at home <75 years | 06-01-2021 | COM/AZ | 356,972 | 196,083 |
Living at home | ||||
90 years and up living at home | 26-01-2021 | COM | 61,258 | 34,345 |
85-89 years | 29-01-2021 | COM | 169,045 | 47,681 |
80-84 years | 05-02-2021 | COM | 305,321 | 5,713 |
75-79 years | 06-03-2021 | COM | 44,066 | 572 |
60-64 years and/or high risk of severe COVID-19 (estimated) | 15-02-2021 | AZ | 154,803 | 0 |
Long-term residential care institutions (estimated) | ||||
|
18-01-2021 | COM/MOD/AZ | 168,241 | 150,010 |
|
25-01-2021 | MOD/COM | 80,597 | 5,419 |
Total | 1,394,603 |
493,123 |
content footnote
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- Direct COVID-19 care and GPs: rounded figures.
- Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
- In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
- A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVM is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
09-03-2021 | 16:30 uur
Vaccinatiecijfers 28 februari tot en met 7 maart 2021
Tot en met zondag 7 maart hebben naar schatting ruim 1,2 miljoen mensen in Nederland tenminste één coronavaccinatie ontvangen en ruim 400.000 mensen een tweede vaccinatie.
Vaccinatiegraad
De voorlopige vaccinatiegraad onder de thuiswonende 90-plussers staat op 64% voor de eerste vaccinatie en op 12% voor de tweede vaccinatie. De vaccinatiegraad onder thuiswonende 85-89-jarigen voor de eerste vaccinatie is 73% en bij de thuiswonende 80-84-jarigen is dat 63%. Onder de thuiswonende 75-79-jarigen is er een klein aandeel van 3% dat een eerste vaccinatie heeft gehad.
De leeftijdsgroep 75-79-jarigen ontvangt sinds afgelopen week een uitnodiging. Een klein aantal heeft iets eerder een eerste vaccinatie ontvangen. Het kan gaan om mensen die gelijk met de groep 80-84-jarigen zijn uitgenodigd, maar die toen nog net geen 80 waren en inwoners van de Waddeneilanden.
Toegeleverde vaccins
In de afgelopen week heeft Nederland 208.260 doses vaccin van BioNTech/Pfizer toegeleverd gekregen en van AstraZeneca 216.480 doses. Moderna heeft in de afgelopen week geen vaccins geleverd.
Vaccinatiecijfers 6 januari t/m 7 maart 2021
Doelgroep | Startdatum | Vaccin | Eerste dosis | Tweede dosis |
---|---|---|---|---|
Directe COVID-19-zorgmedewerkers |
06-01-2021 | COM | 40.000 | 40.000 |
Huisartsen |
22-01-2021 | MOD | 14.300 | 8.300 |
Andere zorgmedewerkers & thuiswonende ouderen <75 jaar | 06-01-2021 | COM/AZ | 304.991 | 195.581 |
Thuiswonenden | ||||
|
26-01-2021 | COM | 59.162 | 11.421 |
|
29-01-2021 | COM | 161.916 | 1.376 |
|
05-02-2021 | COM | 259.307 | 338 |
|
06-03-2021 | COM | 19.259 | 289 |
|
15-02-2021 | AZ | 120.674 | 0 |
Bewoners instellingen voor langdurige zorg (schatting) | ||||
|
18-01-2021 | COM/MOD/AZ | 162.603 | 149.711 |
|
25-01-2021 | MOD/COM | 65.692 | 4.919 |
Totaal | 1.207.904 | 411.935 |
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- Direct COVID-19 care and GPs: rounded figures.
- Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
- In some cases, people aged 75 years and over living at home were already vaccinated before the official start date listed here. Reasons include the following: for practical reasons, people are sometimes invited a bit earlier than the exact moment that they reach the relevant age; on the Wadden Islands, different age limits were used and vaccination already started from 16 February 2021 on for people aged 75-79 years (and 60-79 years for Vlieland and Schiermonnikoog); some care workers continued to work after reaching retirement age; and some people who live in an institution may have been vaccinated by the Municipal Health Service (GGD).
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
- A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
02-03-2021 | 16:45 PM
Weekly update on COVID-19 vaccination: 21 to 28 February 2021
By Sunday 28 February, it is estimated that more than 1,000,000 people in the Netherlands had received at least one COVID-19 vaccination.
Vaccination started last week for mental health clients in inpatient or residential care at four large institutions and the mental healthcare workers employed there; they are being vaccinated by the institution’s own medical department. District nurses also started receiving their vaccinations last week.
Vaccination coverage among elderly people living at home has increased. The first COVID-19 jab for those living at home has been given to 61% of people over 90, 68% of people aged 85-89, and 42% of people aged 80-84. These percentages will increase even more in the next few weeks, when more people from these groups have received their vaccinations.
Second vaccination
More than 331,000 people are estimated to have received their second vaccination.
Vaccine deliveries
In the past week, the Netherlands received 200,070 doses of the Pfizer/BioNTech vaccine, 72,000 doses of the Moderna vaccine and 148,390 doses of the AstraZeneca vaccine.
Vaccination figures 6 January to 21 February 2021
Target group | Start date | Vaccine | First dose | Second dose |
---|---|---|---|---|
Care workers providing direct COVID-19 care |
06-01-2021 | COM | 40,000 | 40,000 |
GPs |
22-01-2021 | MOD | 14,300 | 3,000 |
Other care workers & older people living at home <80 years | 06-01-2021 | COM/AZ | 297,919 | 192,556 |
90 years and up living at home | 26-01-2021 | COM | 56,747 | 196 |
85-89 years | 29-01-2021 | COM | 150,859 | 200 |
80-84 years | 05-02-2021 | COM | 172,523 | 214 |
60-64 years and/or high risk of severe COVID-19 (estimated) | 15-02-2021 | AZ | 63,002 | 0 |
Long-term residential care institutions (estimated) | ||||
|
18-01-2021 | COM/MOD/AZ | 156,477 | 92,988 |
|
25-01-2021 | MOD/COM | 52,930 | 2,517 |
Total | 1,004,757 |
331,671 |
- ambulances for COVID-19 care.
- Direct COVID-19 care and GPs: rounded figures.
- Other care workers: care workers in nursing homes, clinical specialist rehabilitation and disability care.
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- People aged 60-64 years and/or high risk of severe illness from COVID-19: Due to the limited availability of the AstraZeneca vaccine, the first invitations will go to all people born in 1956 or 1957. Groups that have a high risk of severe illness resulting from COVID-19 will also be vaccinated. This initially concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). The staff of the GP practices will also be vaccinated.
- COM= Comirnaty® (Pfizer/BioNTech); MOD= COVID-19 Vaccine Moderna®; AZ= COVID-19 Vaccine AstraZenceca®; for the vaccines currently available, 2 doses are recommended.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate fully between other care workers and older people living at home. However, it is possible to differentiate people with a registered age of 80 years or older. If age is unknown, they are shown in the group <80 years.
- A continuous data flow is not yet available for the number of people vaccinated in institutions and vaccinated by GPs (60-65 years and/or high risk of severe COVID-19). Therefore, the number of doses issued to vaccination sites as ordered by RIVM National Institute for Public Health and the Environment is temporarily used as an estimate for these target groups. For Comirnaty® (Pfizer/BioNTech), it is assumed that these doses are administered on the day that they are provided and during the following three days in equal segments (25% per day). For vaccination by GPs through out-of-hours medical centres, it is assumed that vaccination does not take place at weekends, and that when they receive deep-frozen Comirnaty®, it is used over the course of ten working days. It is assumed that COVID-19 Vaccine Moderna® is administered in the course of nine working days, and that COVID-19 Vaccine AstraZeneca ® is administered in the course of ten working days (in the case of GPs: ten working days excluding the day of delivery). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech), 10 doses per vaccine vial for COVID-19 Vaccine Moderna® and 11 doses per vaccine vial for COVID-19 Vaccine AstraZeneca®.
16-2-2021 | 16:00 PM
Weekly update on COVID-19 vaccination: 7 to 14 February 2021
By Sunday 14 February 2021, it is estimated that about 629,000 people in the Netherlands had received their first COVID-19 vaccination. Starting last week, the first care workers in disability care and rehabilitation care are receiving their first vaccination with the AstraZeneca vaccine. Nursing home staff who had not been able to schedule an appointment yet are also included in this round.
GP practices also started vaccinations yesterday for the first people aged 60-64 and for people who have a high risk of severe illness resulting from COVID-19. In this round, this concerns people with Down’s Syndrome and people with morbid obesity (BMI >40). They will also receive the AstraZeneca vaccine.
Second vaccination
More than 154,400 people are estimated to have received their second vaccination. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2.
Vaccine deliveries
In the past week, the Netherlands received 159,120 doses of the Pfizer/BioNTech vaccine, 95,040 doses of the AstraZeneca vaccine and 38,400 doses of the Moderna vaccine.
Vaccination figures 6 January to 14 February 2021
Target group | Start date | Vaccine | First dose | Second dose |
---|---|---|---|---|
Care workers providing direct COVID-19 care |
06-01-2021 | COM | 40,000 | 40,000 |
Nursing home staff/people aged 80+ living at home |
06-01-2021 | COM/AZ | 414,776 | 97,616 |
GPs |
22-01-2021 | MOD | 14,300 | 0 |
People living in long-term care institutions (estimated) | ||||
People living in nursing homes and care institutions with an institutional physician | 18-01-2021 | COM | 152,006 | 16,829 |
People living in small-scale residential facilities under GP care | 25-01-2021 | MOD | 7,911 | 0 |
Total | 628,993 | 154,445 |
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- Direct COVID-19 care and GPs: rounded figures.
- COM=Comirnaty® (BioNTech/Pfizer); MOD= COVID-19 Vaccine Moderna®; two doses are recommended for the vaccines that are currently available.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between nursing home employees and people aged 80+ living at home.
- A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses issued to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses issued to the vaccination sites as ordered by RIVM. These doses are administered on the day that they are provided and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.
9-2-2021 | 16:20 PM
Weekly update on COVID-19 vaccination: 1 to 7 February 2021
By Sunday 7 February, more than 500,000 people in the Netherlands had received their first COVID-19 vaccination. That also includes about 13,600 GPs. Last Friday, the first people in the age group from 80-84 years received an invitation to make an appointment for a COVID-19 vaccination at a Municipal Public Health Service (GGD).
Second vaccination
More than 66,000 people have received their second vaccination. 40,000 of these are employed in hospital care directly related to COVID-19. This group is now fully vaccinated. With the current vaccines, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2.
Vaccine deliveries
The Netherlands received the first vaccines from AstraZeneca last week: 79,200 doses. In addition, another 159,120 doses of the Pfizer/BioNTech vaccine were delivered in the past week.
Vaccination figures 6 January to 7 February 2021
Target group | Start date | Vaccine | First dose | Second dose |
---|---|---|---|---|
Care workers providing direct COVID-19 care |
06-01-2021 | COM | 40,000 | 40,000 |
Nursing home staff/people aged 80+ living at home |
06-01-2021 | COM | 294,633 | 26,409 |
GPs |
22-01-2021 | MOD | 13,600 | 0 |
People living in long-term care institutions (estimated) | ||||
People living in nursing homes and care institutions with an institutional physician | 18-01-2021 | COM | 151,584 | 0 |
People living in small-scale residential facilities under GP care | 25-01-2021 | MOD | 4,919 | 0 |
Total | 504,736 | 66,409 |
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- People living in residential institutions: this mainly concerns residents, but if there is any vaccine left over, it is also given to employees of these institutions.
- Direct COVID-19 care and GPs: rounded figures.
- COM=Comirnaty® (BioNTech/Pfizer); MOD= COVID-19 Vaccine Moderna®; two doses are recommended for the vaccines that are currently available.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between nursing home employees and people aged 80+ living at home.
- A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses issued to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses issued to the vaccination sites as ordered by RIVM National Institute for Public Health and the Environment . These doses are administered on the day that they are provided and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.
2-2-2021 | 17:55 PM
Weekly COVID-19 vaccination update: 25-31 January
By Sunday 31 January, 327,834 people in the Netherlands had received their first COVID-19 vaccination. 15,692 healthcare professionals have received their second COVID-19 vaccination by now. Last week, the Netherlands received 191,880 doses of the Pfizer/BioNTech vaccine and 19,200 doses of the Moderna vaccine.
In addition to the target groups that are already being vaccinated, vaccination of people aged 90 years and up also started this past week. On Friday 29 January, the first people aged 85-89 years received an invitation to make a vaccination appointment at a GGD vaccination site.
Second vaccination
With the vaccines that are currently in use, a second vaccination is required for optimal protection against the coronavirus SARS-CoV-2. In the week of 25 to 31 January, 13,500 care workers in acute COVID-19 care received a second vaccination. They are now fully vaccinated. The second vaccination round for nursing home employees also started last week.
Vaccination figures 6 to 31 January 2021
Target group | Start date | Vaccine | Number of people who have started vaccination | Number of people who are fully vaccinated |
---|---|---|---|---|
Direct COVID-19 care |
06-01-2021 | COM | 40,000 | 13,500 |
Nursing home staff/people aged 85+ living at home |
06-01-2021 | COM | 186,008 | 2,192 |
GPs |
22-01-2021 | MOD | 6,000 | 0 |
Long-term care institutions (estimated) | 18-01-2021 | COM/MOD | 95,826 | 0 |
Total | 327.834 | 15,692 |
- Direct COVID-19 care: care workers who provide direct COVID-19 care (clinical and ICU), emergency care and the ambulances for COVID-19 care.
- Direct COVID-19 care and GPs rounded to thousands.
- Vaccination started = one dose received
- Fully vaccinated = has received the total number of doses recommended by the manufacturer for that vaccine brand. For the currently available vaccines, this is 2 doses. COM=Comirnaty® (Pfizer/BioNTech); MOD=COVID-19 Vaccine Moderna®.
- In the data provided by GGD GHOR Netherlands from CoronIT, it is not yet possible to differentiate between target groups. For that reason, the table displays the combined group designated ‘Nursing home staff / people aged 85+ living at home’.
- A continuous data flow for the number of vaccinated people in institutions is not yet available. Therefore, an estimate based on the number of doses delivered to vaccination sites is temporarily used for this target group. This estimate is based on the numbers of doses delivered at the vaccination sites as ordered by RIVM National Institute for Public Health and the Environment . These doses are administered on the day of delivery itself and during the following three days. The assumption here is that this is done in equal segments (25% per day). RIVM takes 5% wastage into account and assumes 6 doses per vaccine vial for Comirnaty® (Pfizer/BioNTech) and 10 doses per vaccine vial for COVID-19 Vaccine Moderna®.
26-1-2021 | 17:01 PM
More than 160 thousand people vaccinated in total
During the week of 18 to 24 January, more than 80 thousand people were vaccinated. Most of these were mainly care workers. Residents of institutions for people with intellectual disabilities and nursing homes also received their first vaccination. All vaccinated people still need to receive a second vaccination for optimal protection. In total, more than 160,000 people had been vaccinated by 24 January.
As of 19 January, RIVM is publishing a weekly update on figures from the COVID-19 vaccination programme. The coronavirus dashboard provided by the Dutch Government has also started publishing COVID-19 vaccination figures as of today. The RIVM report does not yet include figures on vaccinations in nursing homes and administered to GPs, because a continuous data flow has not yet been achieved.
Nursing home residents, people with intellectual disabilities living in an institution, and GPs
On Monday 18 January, vaccination started for residents of nursing homes and institutions for people with intellectual disabilities. They are receiving the Comirnaty® vaccine manufactured by Pfizer/BioNTech. Based on an initial inventory by RIVM among the 12 nursing homes and care institutions where vaccination has started, approximately 17,000 people have received vaccinations so far. That includes about 2,000 care workers. Vaccination of the first general practitioners (GPs) started on Friday 22 January. They are receiving the COVID-19 Vaccine® manufactured by Moderna. Vaccination roll-out for GPs is still ongoing.
New data
Reporting was expanded this week to include the doses of COVID-19 vaccines that have been delivered. In the week of 18 to 24 January, the Netherlands received 92,430 doses from manufacturer Pfizer/BioNTech. Over 200 thousand vaccinations will be administered this week. At this point, the percentage of vaccinated people in the Dutch population is not yet high enough to have a visible impact on the course of the epidemic.
Vaccination figures 6 to 24 januari 2021
Target group | As of | Number of people who have started vaccination | |
---|---|---|---|
Care workers | 146,612 | ||
Hospital employees in acute care | 06-01-2021 | 40,000 | |
Nursing home employees | 06-02-2021 | 106,612 | |
Total | 146,612 |
• Hospital employees in acute care: nurses and doctors in the intensive care units, emergency department, COVID-19 wards and on ambulance crews.
19-1-2021 | 16:22 uur
Weekly RIVM update on vaccination figures
As of today, RIVM will be publishing an update every Tuesday on figures from the COVID-19-vaccination programme. Initial figures on the number of vaccinations that have been administered will be reported this week. The data will be updated and supplemented in the next few weeks. Eventually, the data will also be available in open data sets and on the coronavirus dashboard provided by the Dutch Government.
The Netherlands started vaccinating on 6 January. By Sunday 17 January, nearly 77,000 care workers in total had received their first COVID-19 vaccination. In hospitals, some 40,000 care workers in acute care directly related to COVID-19 were vaccinated within a week and a half. In the same period, about 37,000 nursing home employees received a vaccine through the Municipal Public Health Services (GGDs). These people were vaccinated with the Comirnaty® vaccine manufactured by Pfizer/BioNTech and will receive a second vaccination in the coming weeks. Based on the current figures, this has not yet had a visible effect on the course of the epidemic.
Vaccination figures 6 to 17 januari 2021
Target group | Number of people who have started vaccination | |
---|---|---|
Care workers | 77,000 | |
Hospital employees in acute care | 40,000 | |
Nursing home employees | 37,000 | |
Total | 77,000 |
• Hospital employees in acute care: nurses and doctors in the intensive care units, emergency department, COVID-19 wards and on ambulance crews.